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ABSTRACT

Yang, Qianyi. PhD, Purdue University, December 2014. Effects of altered expression of
the sumo conjugating enzyme, UBC9 on mitosis, meiosis and conjugation in
Tetrahymena thermophila. Major Professor: James D. Forney

SUMOylation is a critical posttranslational modification in eukaryotic species. Ubc9p is
the E2-conjugating enzyme for SUMOylation and consequently it influences multiple
cellular pathways. Nuclear proteins are common targets of SUMOylation and regulate
nuclear events such as transcription, DNA repair and mitosis. The segregation of the
Tetrahymena thermophila genome into two different nuclear compartments provides an
unusual context for the analysis of SUMOylation. Each cell contains a transcriptionally
silent, diploid germ line micronucleus (MIC) that divides by mitosis and a polyploid
transcriptionally active somatic macronucleus (MAC) that divides by an amitotic
mechanism. With the long-term goal to exploit these opportunities we initiated studies of
Ubc9p and therefore indirectly SUMOylation, on the functionally distinct nuclei in T.
thermophila using genetic analysis combined with proteomics study. We found that
complete deletion of the UBC9 gene is lethal. Rescue of the lethal phenotype with a
GFP-UBC9 fusion gene driven by a metallothionein promoter generated a cell line with a
slow growth phenotype in the absence of CdCl2-dependent expression of GFP-Ubc9p.
Altered expression of Ubc9p resulted in differential effects in MICs and MACs. MICs
were lost from cells during vegetative growth but MACs were capable of division.
Interestingly, cells expressing a catalytically inactive dominant negative Ubc9p (DNUbc9p) accumulated multiple MICs. Ubc9p depleted cells were hypersensitive to DNA
damaging agents that promote double-strand DNA breaks. Additional studies point to
critical roles for Ubc9p during the sexual life cycle of Tetrahymena. Crosses between cell
lines expressing the dominant negative Ubc9p were delayed in meiosis and produced
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fewer exconjugant progeny who successfully completed genetic exchange and
conjugation than from wild-type controls. In contrast, cell lines that were depleted for
Ubc9p did not form pairs and therefore could not complete any of the subsequent stages
of conjugation including meiosis and macronuclear development. The results are
consistent with roles for Ubc9p in mitosis, meiosis and double strand break repair. A
proteomics-based approach generated an unbiased spectrum of Ubc9p interacting
proteins during Tetrahymena vegetative growth and conjugation. We identified 128 highconfidence Ubc9p interacting proteins during Tetrahymena vegetative growth and 106
proteins during conjugation, among which 58 are conjugation-specific. Seven proteins
with homologs in other species have been reported previously as SUMO substrates, or
Ubc9p interacting proteins. The Ubc9p interactome covers a wide range of cellular
processes, including chromatin remodeling, cell cycle progression, stress response, gene
transcription and Tetrahymena macronuclear development, which further support our
observations from phenotypic analysis. The findings provide evidence for distinct roles
for SUMOylation in ciliate nuclei and provide opportunities for future studies of
SUMOylated substrates in a context specific for gene expression (MAC) or mitotic and
meiotic division (MIC).
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CHAPTER 1 INTRODUCTION

SUMOylation
SUMOylation is a reversible post-translational modification of lysine residues
that targets a diverse set of proteins and regulates a wide range of pathways including
mitosis, meiosis, transcription and DNA repair [1-4]. SUMO (Small Ubiquitin-related
MOdifier) is a small polypeptide (75-89 amino acids) with structural similarity to
ubiquitin [5]. It attaches via isopeptide bonds to lysine side chains through a series of
enzymatic steps catalyzed by E1, E2 and E3 complexes that are analogous to but
independent from those used for ubiquitin addition. Nevertheless, the functions of those
two modifications are different. The primary (but not exclusive) function of ubiquitin
modification is targeting proteins for proteolytic degradation, on the other hand,
SUMOylation alters the intracellular localization, protein-protein interactions or other
types of post-translational modifications of the target [1,3]. While most SUMO substrates
are found in the nucleus, increasing evidence indicates that SUMOylation can regulate
processes in the cytoplasm, membrane and mitochondria such as Ion channel activity,
nuclear export/import, mitochondrial fusion [6-8]. SUMOylation has an emerging role as
a key regulator in gene expression, chromosome stability, cell cycle regulation and DNA
repair [1-4,9].
All eukaryotic SUMO proteins are expressed as precursor proteins that must be
processed by a C- terminal hydrolase to expose the C-terminal di-glycine of the mature
protein [10]. The mature SUMO reacts with ATP in the Uba2-Aos1 SUMO activating
(E1) complex to form a SUMO-adenylate conjugate [11] that is subsequently attacked by
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a conserved cysteine on the Uba2 subunit to form an Uba2-SUMO thioester bond [12]
(Fig. 1). Next, SUMO is transferred from Uba2 to the E2 conjugating enzyme, Ubc9 [13],
forming a thioester bond between the conserved catalytic site cysteine of UBC9 and
SUMO C-terminal carboxyl group. Lastly, Ubc9p transfers SUMO to substrates, via an
isopeptide bond formed between the SUMO C-terminal glycine residue and a lysine side
chain contained within the substrate. This step is often assisted by a SUMO E3 ligase that
enhances the transfer of SUMO from Ubc9p to targets. Many SUMOylation sites contain
the consensus motif ψKXD/E (where ψ is a large hydrophobic residue, K is lysine, X is
any residue, and D and E are aspartic acid and glutamic acid respectively). These residues
directly interact with E3 and Ubc9p and therefore it has a critical regulatory role in
stabilizing interactions between the E2 enzyme and the substrate [14]. However, it should
be noted that not all ψKXD/E motifs are SUMOylated [3] and SUMO modification can
also occur at other lysine residues.

Fig. 1: SUMO conjugation pathway. SUMO undergoes processing by SUMO proteases to
expose a C-terminal Gly-Gly motif that is required for conjugation. The E1 complex, a
heterodimer of Uba2 and Aos1, catalyzes a thioester bond between the C-terminal of mature
SUMO and the catalytic cysteine in Uba2 an ATP-dependent manner. Then the SUMO is
transferred from the E1 to the catalytic cysteine in the E2 enzyme (Ubc9), forming a
SUMO-E2 thioester intermediate. Finally, SUMO is attached to the amino group of a lysine
residue with in the substrate protein. This ligation reaction is assisted by an E3 enzyme. The
SUMO protein can be released from the substrate by members of the SUMO protease (Ulp)
family. This process is called deSUMOylation.
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Substrate specificity of the SUMO pathway relies mostly on the single SUMO E2
enzyme and a handful of SUMO E3 ligases that have been identified [15-20]. Unlike
Ubiquitin E2 enzymes, the SUMO E2 enzyme in vitro is able to recognize and conjugate
SUMO to targets in the absence of E3 ligases [21]. However, SUMO E3 ligases enhance
the specificity and efficiency of SUMOylation via two proposed mechanisms. First, the
E3 ligase may orient the E2-SUMO thioester bond in a preferable conformation for
catalysis without interacting with the substrate, as is the case for RanBP2 [22].
Alternately, the E3 enzyme could directly interact with the substrate by forming a
complex with the E2-SUMO complex. The Siz and PIAS (Protein inhibitor of activated
STAT) proteins (in humans) are E3 ligases that interact with E2 and SUMO through their
SP-RING domain and Siz/PIAS C-terminal domains respectively [23,24] indicating that
specificity is derived from the combination of interactions between E2, E3 and SUMO.
Substrate recognition can also be regulated by substrate phosphorylation. SUMO
substrates can be phosphorylated at the site adjacent to a SUMO consensus motif, aptly
termed phosphorylation-dependent SUMO motifs (PDSMs) (ψKX(D/E)XXSP where P is
the phosphate moiety on a serine residue). Phosphorylation enhances SUMO conjugation
both in vitro and in vivo [25,26] because the phosphorylated serine side chain interacts
with a basic patch on the E2 surface, increasing interactions with E2 enzyme [27].
Phosphorylation of the transcription factor myocyte-specific enhancer factor 2A
(MEF2A) by cyclin-depended kinase 5 (SDK5) within a PDSM enhances its SUMO
modification, which further inhibits transcription and results in synapse maturation [28].
It should be noted that phosphorylation does not always occur within canonical PDSMs.
Phosphorylation of NF-κB inhibitor α (IκBα) has been reported to inhibit modification by
SUMO, and this phosphorylation occurs on a serine residue outside the PDSM [29].
SUMO E2 enzyme Ubc9
Ubc9 is the single E2 enzyme in the SUMO pathway. Loss of function studies of
Ubc9p in different organisms suggest important roles for SUMOylation in cellular
processes (described below). Although different phenotypes have been reported in
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different species, these studies have revealed that both Ubc9p and the SUMO pathway
play critical roles in mitosis, meiosis and DNA damage repair.
UBC9 and mitosis
Ubc9 in known to regulate several aspects of mitosis including chromosome
segregation, cell cycle progression, kinetochore assembly and cytokinesis [15,30-32].
Some of the first studies demonstrating the requirement of Ubc9p in mitosis were done in
the budding yeast showing that depletion of Ubc9p prevents the cell cycle progression
beyond the G2/M boundary [33]. Degradation of B-type cyclins Clb2 and Clb5, which
are essential for exit from mitosis, requires the Ubc9p protein. In UBC9-depleted cells,
CLB5 and CLB2 were significantly stabilized [33]. Most likely, this resulted from the
absence of SUMO-targeted ubiquitin degradation that was not known at the time. In the
same model system budding yeast, depletion of UBC9 causes cells to arrest with
undivided nuclei and high levels of securin Pds1 which is an anaphase-promoting
complex/C (APC/C) substrate, indicating that SUMOylation is also required for proper
proteolysis mediated by APC/C [34,35]. In contrast, Schizosaccharomyces pombe cells
lacking the UBC9 homologue Hus5 are viable but appear to arrest at S/G2 phase and
show defects in chromosome segregation [35]. Similarly, in the fruit fly Drosophila
melanogaster, one UBC9 mutant, termed semushi, suffers from wide-spread chromosome
mis-segregation during embryogenesis [36]. In vertebrate Xenopus egg extracts,
Topoisomerase II (TOP2) is modified by SUMO-2/3 exclusively during mitosis.
Inhibition of SUMO modification by expression of a dominant-negative Ubc9p increases
the amount of unmodified topoisomerase II retained on mitotic chromosomes and blocks
the dissociation of sister chromatids at the metaphase-anaphase transition, indicating the
importance of SUMO conjugation in chromosome segregation [37]. Conditional
depletion of Ubc9p in chicken cell lines leads to an increase in cells with multiple or
fragmented nuclei, indicating defects in cytokinesis [38]. In contrast to depletion of
Ubc9p in fission yeast and budding yeast, most of the chick Ubc9p depleted cells commit
apoptosis without arresting at any phase of the cell cycle, suggesting the apoptosis is
triggered without activating cell cycle check-point mechanisms when chromosome
damages are accumulated these cells [38]. Loss of Ubc9p in mice leads to embryonic
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lethality in the early post-implantation stage [39]. In culture, homozygous null UBC9
mutant blastocysts are viable up to 2 days but subsequently die of apoptosis. Two types
of mitotic chromosome defects were observed in embryonic Ubc9p deletion mutants: 1) a
significant increase in the size of nearly all metaphase plates; 2) aberrantly segregating
chromosome in anaphase. In addition, nuclear organization is grossly altered in Ubc9p
mutant cells, such as disassembled nucleoli and promyelocytic leukemia (PML) nuclear
bodies [39]
UBC9 and meiosis
A few studies have demonstrated the role of UBC9 in meiosis. The first clue of
SUMOylation in synapsis came from studies in hamster cells lines [40]. Yeast two-hybrid
screens identified Ubc9p as a protein that interacts with the Cor1 and Syn1 components
of the synaptonemal complex (SC). The SC is meiotic structure that promotes both
genetic exchange between chromosome pairs and correct chromosome segregation to
daughter cells during meiosis [40]. Additional studies showed that Ubc9p localized to
meiotic chromosomes in S. cerevisiae and mice [41,42], which suggests that Ubc9p is
associated with and regulates SC structure. A UBC9-GFP fusion led to meiotic defects. A
diploid homozygous of UBC9-GFP mutant reduced meiotic division by 50% of the wildtype level and exhibited decreased sporulation [41]. SUMOylation is also important for
timely synapsis. Synapsis in the same UBC9-GFP mutant was delayed significantly
relative to that in the wild-type. At late times in the UBC9 mutant, chromosomes did
eventually synapsed [41]. In mouse male germ cells, the Ubc9p homolog, UBE2I is
localized to centromeres after SC disassembly [43], implying potential Ubc9p regulation
in non-SC proteins. The yeast two-hybrid system was used to identify Ubc9 interacting
protein in the basidiomycete Corprinus cinereus and revealed that Ubc9p interacts with
the meiosis-specific RecA homolog, Lim15/Dmc1 (CcLim15) [44]. This interaction
mediates SUMOylation of the C-terminus of CcLim15 during meiosis.
Immunocytochemistry demonstrates that CcUbc9 and CcLim15 co-localize in the nuclei
from the leptotene stage to the early pachytene stage during meiotic prophase I. These
results suggest that SUMOylation is a potential mediator of meiotic recombination via
interaction between Ubc9p and Lim15/Dmc1. Recently, Yuan et al showed that
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inhibition of SUMO-1 or Ubc9p using a specific antibody or their depletion by specific
siRNA microinjection in germinal vesicle (GV) - stage oocytes decreased the rates of GV
breakdown and first polar body extrusion, causing defective spindle organization and
misaligned chromosomes leading to aneuploidy in the mature oocyte [45]. In addition to
Ubc9, other SUMO pathway components are known to be indispensable for meiosis. For
example, the SUMO proteases Ulp1, when deleted, exhibits a cell cycle arrest phenotype
at meiotic prophase [46], indicating that SUMO modification or removal is likely to have
specific meiotic functions.
UBC9 and development
In addition to its functions in mitosis and meiosis, UBC9 RNAi knockdown in
Caenorhabditis elegans leads to embryonic arrest after gastrulation. Loss of Ubc9p also
cause pleiotropic defects in larval development in worms that completed embryogenesis
[47]. Reduction of maternal zygotic UBC9 during an early stage of zebrafish
development leads to widespread cell death, but inactivation of zygotic Ubc9p
transcription in the embryo causes defects in development, including brain, eyes and
cartilage formation [48]. Together these studies indicate that in addition to regulating
particular cellular processes, Ubc9p regulates developmental programs in multicellular
eukaryotes.
UBC9 and DNA repair
DNA lesions can occur through exogenous and endogenous agents. One of the
continuous challenges of all organisms is to faithfully replicate their genomes and
maintain them in an error-free state as they undergo cell division. DNA double-strand
breaks (DSBs) represent the most destructive chromosomal lesion and may prove
deleterious if left unrepaired [49,50]. All eukaryotic cells employ sophisticated cellular
networks, collectively termed the DNA damage response (DDR) to constantly monitor
genomic integrity. Increasing evidence suggests that the recruitment of these factors to
the damage site, as well as their turnover is orchestrated by the crosstalk of posttranslational modifications (PTMs) [51], and SUMO is one important player in this
network that regulates the dynamics of DNA repair complexes [52]. Galanty et al showed
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upon DNA damage SUMO-1 and Ubc9p accumulate at repair foci in a pathway that
requires SUMO E3 ligases PIAS1 and PIAS4 [53]. Moreover, the recruitment of receptor
associated protein 80 (RAP80), a key component in DDR pathway, requires PIAS1 and
PIAS4. PIAS1 also affects the recruitment of RNF168, another component in DDR
pathway, as well as its formation of polyubiquitylation [54]
There is increasing evidences for SUMOylation and Ubiquitylation cross-talk in
DNA damage repair. A novel class of Ubiquitin ligases, termed SUMO-targeted
Ubiquitin ligases (STUbL), mediates Ubiquitylation of SUMOylated proteins to target
them for degradation by the proteasome [55-58]. One of the most extensively studied
STUbLs is RNF4 [57-61]. In 2012, both Hay and Jackson laboratories uncovered RNF4mediated SUMO-dependent protein degradation in DDR [62,63]. Cells in which RNF4
expression has been abolished are hypersensitive to DNA damage that requires
Homologous Recombination for its repair, meanwhile, mice deficient in RNF4 display an
accumulation of ionizing radiation-induced DNA damage. RNF4 recruitment to DNA
damage sites requires its SIMs and RING domain, as well as DNA damage factors such
as NBS1, MDC1, RNF8, 53BP1 and BRCA1. Without RNF4, these factors were still
loaded to damage sites but 53BP1, RNF8 and RNF168 showed delayed removal from
such foci. Cells lack of RNF4 displayed defective recruiting RAD51 on to singlestranded DNA, which appeared to be a consequence of reduced recruitment of singlestrand-specific DNA-binding protein replication protein A (RPA) and the CtIP [CtBP(Cterminal-binding protein)-interacting protein] nuclease complex, resulting in inefficient
reaction [62]. These studies indicate that RNF4 plays an important role in homologous
recombination in DNA repair. Prior to the discovery of RNF4, two other RING-finger
proteins in yeast, Slx5p and Slx8p, were identified as members of STUbL family. Both
proteins are required for cellular survival following replication stress and deletion of
either gene causes hydroxyurea sensitivity, meiotic defects and a slow growth phenotype
[64].
DSBs are repaired primarily by two pathways: homologous recombination (HR)
and non-homologous end-joining (NHEJ) [65]. HR is initiated by the MRE11-RAD50-
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NBS1 (MRN) complex that stabilizes DNA ends, promotes the DNA resection, and
triggers the recruitment of ATM [66]. DNA resection is carried out by CtIP [67]. In S and
G2 phase, interaction between CtIP and BRCA1 facilitates DNA end processing [67].
Many other proteins, such as CDK, ATM, MRN, are also involved in the entire process
of DSB resection [68,69]. Next, Rad51/Rad52 are loaded to DSBs where RPA binds to
the ssDNA overhangs. Invasion of a resected end of the DSB into duplex DNA to form
D-loop takes place in the Rad51 filament and both RPA and RAD52 help load Rad51
onto ssDNA to form filament [70]. The newly synthesized fragments ends joined by
DNA ligases that form double Holliday Junctions (dHJs). It has been demonstrated that
SUMOylation is involved in HR. SUMOylation of RPA has been detected in yeast and
mammalian cells [69,71]. SUMOylation of Rad 52 by SUMO E3 ligase Siz2 stabilizes
Rad52 and reduces the DNA binding and single-strand annealing activities of this protein
[72,73].
Apart from repairing DSB damage, homologous recombination also helps restart
stalled or collapsed replication forks. In this regard, SUMOylated proteins that are
relevant to this process include members of RECQ helicase family: BLM (Bloom
syndrome, RecQ helicase) [74], WRN (Werner syndrome, RecQ helicase) in higher
eukaryotes [75], and Sgs1 in budding yeast [76]. However, it is very likely that not all
SUMOylated proteins have been identified and how SUMO affects the activities of these
proteins and subsequently leads to restart of replication forks is still largely unclear.
DSBs in budding yeast are mostly repaired by HR which is considered as a highfidelity way because it essentially involves copying the missing information from its
homologous chromosome in a diploid cell [77]. On the other hand, NHEJ, which is the
more common DSB repair pathway in mammalian systems [78,79], involves holding
broken ends together followed by re-ligation. NHEJ is an imperfect process from the
standpoint of preserving genetic information because a few nucleotides at each end of the
broken DNA are missing in most cases in mammals [80] and in many circumstances
when it is used in yeast [81].
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NHEJ starts with the Ku70/80 heterodimer binding to the ends of dsDNA at the
site of the DSB [82]. DNA-PKcs is recruited to Ku proteins to form the active DNA-PK
protein ligase [83]. Synapsis forms when two broken ends are held together by two DNAPKcs molecules [84,85]. XRCC4/DNA ligase IV complex is recruited to DNA-PKcs to
carry out processing and aligning DNA ends, as well as the DNA ligation [86]. Multiples
NHEJ components are known to be SUMOylated. In humans, XRCC4 is SUMOylated
[87] and XRCC4 mutants that cannot be SUMOylated are hypersensitive to radiation and
fail to complete V(D)J recombination [87]. Ku70 is also SUMOylated in yeast. Ku70
SUMOylation deficiency is associated with short telomeres and internal breaks, as well
as impaired ability to block DNA end resection and suppression of multiple defects
caused by inefficient resection, which in turns alters levels of NHEJ [88].
SUMOylation and ribosome
Several studies showed that SUMOylation is required for pre-ribosomal complex
formation in yeast and higher eukaryotes. Eukaryotic ribosomes are comprised of a small
40S subunit and a large 60S subunit, each of which contains distinct ribosomal proteins
and ribosomal RNA (rRNA). Biogenesis of ribosomes is a tightly regulated process that
involves a large numbers of non-ribosomal proteins, called trans-acting factors, as well as
non-coding RNA species [89,90]. Ribosome biogenesis begins in nucleolus, where 47S
rRNA is transcribed and assembled into large subunit called 90S pre-ribosome complex,
which will further separate into 40S and 60S pre-ribosomes that mature independently in
the nucleolus and cytoplasm. In 2006, Panse et al used a proteomic approach to show that
SUMO targets several trans-acting factors along the 40S and 60S synthesis pathway,
including Ytm1, Nop7 and Rix 1 [91]. When components of SUMO conjugation or
deconjugation are inactivated, several defects in ribosome maturation were observed. For
example, ULP1, which is a SUMO isopeptidase that is homologous to the human SENP
family, is required for early and late pre-rRNA processing and nuclear export of 60S
particle [92]. In humans, deletion of human SUMO-specific-isopeptidase SENP3 strongly
inhibits the nucleolar processing of 32S rRNA to the 28S rRNA and precludes the
subsequent steps of pre-60S maturation [93,94].
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SUMOylation and transcription regulation
Transcription factors are a prominent class of proteins targeted by SUMOylation.
A growing number of SUMO substrates are now allowing attempts to dissect mechanism
of SUMOylation on transcription in detail. Many studies have led to the conclusion that
SUMO modification of transcription factors have a role in transcriptional repression
[95,96]. Also the fact that recruitment of Ubc9p to promoter sequences is sufficient to
repress transcription further supports this idea [97]. The tumor suppressor ING1b is
SUMOylated at Lysine 193 in human [98]. The SUMO attachment to ING1b regulates its
binding to the ISG15 and DGCR8 promoters, which regulates ISG15 and DGCR8
transcription [98]. Forkhead box transcription factor M1 (FoxM1) is SUMOylated in
mice [99]. FoxM1 is a key regulator of cell-cycle progression and chromosome
segregation. SUMOylation-deficient FoxM1 mutant is less active compare to wild-type
FoxM1, indicating that SUMOylation of FoxM1 enhances its transcriptional activity [99].
Increased global acetylation was observed in yeast with reduced SUMOylation due to
down-regulation of UBC9 which is consistent with the role of SUMOylation in repressing
transcription given the association between acetylation and gene transcription activation
[100]. Alongside with evidences of SUMO in transcription repression, there are also a
few reports where SUMO has been shown to activate transcription. For example,
SUMOylation of p53 results in an increased transactivation of p53, which suggests a
novel mechanism to regulate p53 activity [101,102]
UBC9 autoSUMOylation
SUMOylation of Ubc9p has been observed in mammalian cells in vitro [103-105].
SUMOylation of Ubc9p was also observed in yeast in the analysis of global SUMOylated
proteins [106,107]. Studies by Knipscheer et al have revealed that Ubc9p is
SUMOylation at Lys-14 in mammalian cells regulates target discrimination [105].
SUMOylation of Ubc9p does not seem to affect Ubc9-SUMO thioester bond formation
but rather alters the capability of Ubc9p to modify particular SUMO substrates. For
example, SUMOylation of Ubc9p impairs SUMOylation of RanGAP1 and strongly
activates SUMOylation of the transcriptional regulator Sp100, whereas its activity toward
HDAC4, E2-25K, PML, or TDG is not changed. Hwang et al report that SUMOylation of
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Ubc9p in yeast negatively regulates SUMOylation of septins and Ubc9p
autoSUMOylation is important for maintaining cell morphology [108]. Interestingly,
Sp100 contains a SUMO interaction motif (SIM), a non-covalent SUMO binding
mechanism, which is required for the enhanced SUMOylation of Sp100 by Ubc9p
autoSUMOylation [105]. This suggests that SIM-mediated recruitment of SUMOylated
Ubc9p to substrates may represent a novel mechanism of substrate specificity. More
recently, studies by Klug et al have identified Ubc9p SUMOylation as a key regulatory
step for synaptonemal complex (SC) formation. Yeast containing a Ubc9p mutant that
could not be SUMOylated showed a significant reduction of SUMO conjugants during
meiosis and failed to form a synaptonemal complex [109]. This study has revealed a
mechanism for E2 regulation that orchestrates catalytic and non-catalytic functions of
Ubc9.
In addition to the covalent interaction between Ubc9p and SUMO, Ubc9p also
interacts with SUMO in a non-covalent manner, where SUMO interacts with Ubc9p at its
N-terminus rather than the Cysteine active site [110]. It has been shown that non-covalent
Ubc9p-SUMO interaction promotes SUMO chain formation in yeast [111], but other than
that the role of this interaction is largely obscure.
Tetrahymena provides advantages in studying SUMOylation
Tetrahymena thermophila is a ciliated unicellular eukaryote. Like other ciliates
Tetrahymena displays “nuclear dimorphism”; the germ-line and somatic genomes are
segregated into separate nuclei called the micronucleus (MIC) and macronucleus (MAC)
respectively. The diploid micronuclei possess features of typical eukaryotic nuclei; they
divide by mitosis during vegetative cell division and undergo meiosis during sexual
reproduction, also known as conjugation. The micronucleus is transcriptionally inert and
gene transcription is limited to the macronucleus, which is composed of an amplified
subset (45 copies) of the sequences present in the MIC. Both nuclei replicate their
genomes and divide during vegetative growth, but the MAC divides by an amitotic
process.
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Vegetative cell division
MICs and MACs replicate their DNA at different points in the cell cycle
[112,113]. In non-dividing cells, the MIC rests in a pocket in the MAC. Division of the
MIC starts first, followed by amitotic division of the MAC that does not have functional
centromeres. When mitosis starts, the MIC becomes spindle shape and is still halfattached to the MAC. Next, the MIC is detached from the MAC and becomes a thin
thread, which quickly becomes shortened and disappears, leaving the MIC directly
attached to the cortex on one end and to the MAC on the other end. In the meantime, the
MAC moves from its central position to a place near the cortex adjacent to the MIC. The
spindled MIC then gets stretched and divides and returns to the MAC following
cytokinesis. During MAC amitotic division, the MAC shape becomes irregular for a short
period of time and then becomes rod shape followed by its fission that coincides with the
division of the cell.
MAC chromosomes segregate randomly between the two daughter cells during
division, as a result, heterozygous progeny will become pure for one allele or the other
[114]. This phenomenon is called phenotypic assortment and it can be utilized to generate
a MAC gene knockout in Tetrahymena if the gene is not essential for vegetative growth.
In Tetrahymena, nuclear dimorphism allows the creation of cells that are
genetically different in the MIC and MAC [115]. Combined with phenotypic assortment,
scientists are able to construct genetically useful strains that carry a non-expressed
mutation in the MIC but express only the non-expressed mutant in MAC, which can be
either homozygous or heterozygous. Mutations in essential genes can be maintained as
heterokaryons, containing the lethal mutation in the MIC and a wild-type MAC. Only
after mating will the lethal genotype be expressed in the newly formed MAC that is
generated from the MIC genome.
Conjugation
Conjugation is the sexual stage of the Tetrahymena life cycle. Cells must be
starved for a period of time in order to be mating reactive. Mating pairs form between
two cells of different mating types. There are two primary events during conjugation:
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meiosis and macronuclear development. MIC meiosis starts at ~2h after cells are mixed.
It elongates to form an unusual crescent shaped MIC that corresponds to meiotic
prophase, during which chromosome pairing and recombination occurs. Following the
crescent stage, the chromosomes condense and standard meiotic divisions occur, giving
rise to four haploid products, one of which is selected for survival and the other three are
destroyed. The selected meiotic product undergoes mitosis to produce two identical
haploid pronuclei, one of which remains in the cell and the other is transferred to the
mating partner. The migratory and resident nuclei in each cell fuse producing one diploid
zygotic MIC in each partner. The zygotic MIC undergoes two rounds of mitosis,
generating four diploid nuclei, one of which develop into MICs and two become MACs.
Eventually, the parental MAC condenses and is degraded (Fig. 2).

Fig.2: Tetrahymena life cycle. Cells of two different mating types are mixed and pair at
1.5 hours post-mixing. MIC undergoes meiosis by elongated into a crescent shape, which
corresponding to meiotic prophase I. MIC then will divide twice, generating four haploid
nuclei, only one of which is selected and retained. This round of division is terms prezygotic division. The surviving progeny will form a zygotic nuclei with its counterpart
from its partner. Events involved in this process include chromosome pairing and crossover. Two post-zygotic mitosis produce four diploid, two of which develop into new
MACs and two of which will become new MICs. During this time, massive DNA
rearrangement occur. After feeding, the first cell division occurs as the cells return to
vegetative growth.

As the macronuclear anlagen develops, the genome undergoes a massive
reorganization. The five micronuclear chromosomes are broken down into approximately
180 macronuclear chromosomes [116]. The single-copy of micronuclear rDNA is
amplified to a copy number of about 10,000 per cell [117]. Approximately 6000 specific
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DNA elements, called internal eliminated sequences (IES) are removed from the genome,
at the same time the genome in the macronuclear anlagen undergoes several rounds of
DNA replication without cell division, resulting in a total of approximately 45 copies of
each MAC chromosome.
IES elimination is an extensively studied process in Tetrahymena [118,119]. The
removal of these elements is accompanied by the generation and ligation of DNA DSBs,
which makes Tetrahymena a wonderful system to study DSB repair.
IES elimination is an RNA-directed event, which depends on the RNA
interference pathway. The genome of the micronucleus is bidirectionally transcribed
early in conjugation. The resulting double-strand RNA is processed by a Dicer-like
enzyme to 28bp scanRNA (scRNA), which are incorporated into a complex containing an
argonaute protein Twi1p [120]. The mechanism for scRNA identification of DNA that
should be eliminated during MAC development is not fully established, but the current
model has the following features. The parental MAC genome is scanned by the scRNA
complexes and those complexes containing scRNAs with homology to macronuclear
sequences are degraded. The remaining complexes that are complementary to MIClimited sequences are transported to the developing macronucleus, where they identify
their homologous DNA sequence and induce formation of specialized heterochromatin
that is subsequently excised from the germline genome [118,119].
The synchronous molecular events of Tetrahymena conjugation including
meiosis, RNAi scanning, programmed double strand DNA breaks and repair provide a
potential rich system for the analysis for SUMOylation.
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CHAPTER 2 DEPLETION OF UBC9 CAUSES DEFECTS IN SOMATIC AND
GERMLINE NUCLEI IN TETRAHYMENA THERMOPHILA

Introduction
Post-translational modification by Small Ubiquitin-related MOdifier (SUMO) is a
major regulator of protein function. The mechanism of SUMO attachment to substrates
shares common features with ubiquitin but unlike ubiquitin, which primarily targets
proteins for proteasome-mediated protein degradation, SUMOylation alters the
intracellular localization, protein-protein interactions or other types of post-translational
modifications of the target [2,4]. The importance of SUMOylation as a modification is
evident in its regulation of progression through the cell cycle, transcription, subnuclear
architecture, chromosome stability, and nuclear-cytoplasmic transport, mitosis and
meiosis, and DNA damage repair [1,3,9,53]. SUMO proteins are ubiquitously expressed
across eukaryotes and proteins required for SUMOylation, such as Uba2p and Ubc9p, are
highly conserved from yeast to human. Like ubiquitin, SUMO proteins are expressed as
precursors that need to be proteolytically processed by C-terminal hydrolases to expose a
C-terminal Gly-Gly motif which participates in the isopeptide bond with lysine residue
on substrate proteins [12]. The mature SUMO proteins are activated by the heterodimeric
E1 activating enzyme comprising Aos1p-Uba2p subunits [11] in an ATP-dependent
reaction. Subsequently, SUMO is transferred from the E1 enzyme active site Cys to a Cys
residue-linked thioester bond in the E2 enzyme known as Ubc9p [13]. In the last step,
SUMO is attached to the target protein through a Lys-linked isopeptide bond. In vitro,
conjugation of SUMO onto substrates can be done directly by Ubc9p; in vivo, E3 ligases
increase the specificity and efficiency of the reaction [29,121].
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Ubc9 is the only known SUMO E2 enzyme and therefore a key modulator of
SUMOylation. Ubc9p was first described as an essential protein for mitosis in fission
yeast [33]. Studies in several eukaryotes highlight its importance in multiple aspects of
mitosis, including chromosome integrity and segregation, cell cycle progression,
kinetochore assembly, and cytokinesis [35,39,122]. In Xenopus egg extracts the
dissociation of sister chromatids is blocked at the metaphase-anaphase transition when
SUMOylation of topoisomerase-II is inhibited by a dominant negative Ubc9p [37]. Loss
of Ubc9p in mice leads to embryonic lethality during the early post-implantation stage
and results in selective apoptosis of cells of the inner cell mass (ICM) in blastocysts [39].
Reduction of Ubc9p activity in zebrafish also shows that Ubc9p is required for G2/M
transition and progression through mitosis during vertebrate organogenesis [48].
Apart from its function in mitosis, UBC9 has also been shown to be involved in
DNA damage repair and tumorigenesis. SUMOylation has been demonstrated to play
important roles in the repair of DNA double-strand breaks (DSBs) via Homologous
Recombination (HR) and Non-Homologous End-Joining (NHEJ). For example, as key
components of HR machinery, both Rad51 and Rad52 are shown to interact with both
SUMO1 and Ubc9p [42,73,123]. Depletion of Ubc9p causes signiﬁcant disruption of
Rad51 intracellular trafﬁcking, which causes the inhibition of Rad51 nuclear foci induced
DNA damaging agents [124]. SUMO1/2 and Ubc9p are shown accumulated to the DSBs,
suggesting their roles in DSBs repair [53].
Although investigations of SUMOylation in ciliated protozoa have lagged behind
other species, they offer a unique platform for studies of nuclear functions of
SUMOylation. Like other ciliates Tetrahymena thermophila displays “nuclear
dimorphism” where germ-line and somatic genomes are separated in the micronucleus
(MIC) and macronucleus (MAC) respectively [125]. The diploid micronuclei possess
features of typical eukaryotic nuclei; they divide by mitosis during vegetative cell
division and undergo meiosis during sexual reproduction, also known as conjugation.
Unlike a typical eukaryotic nucleus, the micronucleus is transcriptionally inert and gene
transcription is limited to the macronucleus, which is composed of an amplified subset
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(~45 copies) of the sequences present in the MIC. Both nuclei replicate their genomes
and divide during vegetative growth, but the MAC divides by an amitotic process.
Previous studies demonstrated that RNAi gene silencing of UBA2 and SUMO in
Paramecium tetraurelia had little effect on vegetative cells but prevented the excision of
short regions of DNA called internal eliminated sequences (IESs) during formation of the
somatic macronucleus [126].
We initiated this study to evaluate the contribution of Ubc9p, and therefore indirectly
SUMOylation, on the functionally distinct nuclei in Tetrahymena. We found that
complete deletion of UBC9 was lethal, but reduced expression of Ubc9p resulted in
distinct phenotypes in MICs and MACs. The MICs were lost from cells during vegetative
growth and MACs were capable of division. However, cells expressing catalytically
inactive dominant negative Ubc9p (DN-Ubc9) have multiple MICs. Ubc9p depleted cells
also were hypersensitive to DNA damaging agents that promote double-strand DNA
breaks. Additional studies point to critical roles for Ubc9p during the sexual life cycle of
Tetrahymena. Crosses between cell lines that express the dominant negative Ubc9p were
delayed in meiosis and resulted in fewer true exconjugant progeny than from wild-type
controls. In contrast, cell lines that were depleted for Ubc9p did not form pairs and
therefore could not complete any of the subsequent stages of conjugation including
meiosis. The findings provide evidence for distinct roles for SUMOylation in ciliate
nuclei and provide opportunities for studies of SUMOylated substrates in a context
specific for gene expression (MAC) or mitotic and meiotic division (MIC).
Materials and Methods
Strains and cell culture. Tetrahymena thermophila cell lines were obtained from the
Tetrahymena Stock Center (Cornell University, Ithaca, NY). Cells were cultured in
1×SPP media (2% proteose peptone, 0.1% yeast extract, 0.2% glucose and 0.003%
FeCl3) at 30 °C according to established procedures [127]. Inbred wild type strains
B2086 (mpr1-1/mpr1-1 [mpr1; mp-s, II]) and CU428 (mpr1-1/mpr1-1 [MPR1; mp-s,
VII]) were used for cell transformation and all other analysis. Star strains B*(VI) and
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B*(VII) that possess defective micronuclei but wild-type macronuclei were used for
generating UBC9 homozygous germline knockout strains [115,128-130]
Construction of plasmids. A Tetrahymena UBC9 knockout construct (pUBC9KO) was
generated by ligating UBC9 flanking sequences into pMNBL, which contains a neomycin
selectable cassette expressed via the metallothionein 1 (MTT1) promoter from T.
thermophila [131]. UBC9 upstream sequences (1202 bp; 354,009 to 355,211 of scaffold
8254664) were amplified by PCR using phusion DNA polymerase (Thermo Fisher
Scientific), genomic DNA template from wild-type strain B2086 and the knockout
cassette primers shown in Table 1. The PCR product was cloned into the unique XhoI and
BglII restriction sites of pMNBL. The corresponding downstream flanking sequences
(1404 bp; 356,442 to 357846 of scaffold 8254664) were amplified and cloned into the
unique BamHI and NotI restriction sites. The bacterial neomycin gene, which confers
paromomycin resistance (pm-r) on transformed cells, is expressed from the CdCl2 (Cd)inducible MTT1 promoter.
A GFP-UBC9 fusion construct was made in a pENTR Gateway plasmid (Life
Technologies). The 997 bp coding region of the UBC9 gene (TTHERM_00522720) from
the second codon to the TGA stop, was PCR amplified and cloned into the pENTR-D
entry vector. The gene cassette in the entry vector was then inserted into a pBS-MTTGFP-gtw destination vector (Doug Chalker, Washington University, St. Louis, MO)
using the LR recombinase in the Gateway cloning system (Life Technologies).
Successful insertion of GFP-UBC9 fusion gene at the rpl 29 locus confers cycloheximide
resistance.
Endogenous C-terminal mCherry fusions were made in the plasmid pmCherryLAP-NEO2
as described previously [132]. Approximately 1 kb of the 3’ end of UBC9 gene was
ligated into the KpnI and NotI sites adjacent to the mCherryLAP tag and 1 kb of the 3’
downstream sequence was placed adjacent to the NEO2 selectable marker, which confers
paromomycin resistance.
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The dominant negative UBC9 (pDN-UBC9) construct was generated by inserting an Nterminal (His)6-FLAG tagged version of UBC9 containing a mutation of the catalytic
cysteine in the 100th position to a serine residue. The gene was chemically synthesized
by IDT (Coralville, Iowa) with BsiWI and ApaI restriction sites adjacent to the 5’ and 3’
coding regions respectively. The coding region was then inserted into the plasmid pBSMTT-YFP-gtw (obtained from Doug Chalker, Washington University, St. Louis) after
digesting with BsiWI and ApaI. The construct was linearized by HindIII digest and
transformed into Tetrahymena. This plasmid integrates adjacent to the rpl29 locus and
confers resistance to cycloheximide (12.5 µg/ml).
Construction of UBC9 germline knockout. Plasmid pUBC9KO was purified using a
Qiagen Plasmid Maxi kit (Qiagen) and was linearized with XhoI and NotI digestion. The
DNA was coated with 0.6 mM gold particles (S550d DNAdelTM Gold carrier particles,
Seashell Technology, LLC) and introduced into mating B2086 and CU428 populations
2.5 to 3.5 h post-mixing [133] by biolistic bombardment as described previously [134].
Putative transformants with UBC9 disrupted (ΔUBC9) within micronuclei were selected
by growth in the presence of paromomycin (100 µg/mL) followed by 6-methylpurine (7.5
µg/mL). The heterozygous (ubc9::neo3/ubc9 [pm-r]) transformants were crossed to star
strains B*VI and B*VII to generate two homozygous germ line-knockout heterokaryon
strains, BVI ΔUBC9 (ubc9::neo3/ubc9::neo3 [VI, UBC9+ pm-s]) and BVII ΔUBC9
(ubc9::neo3/ubc9::neo3 [VII, UBC9+ pm-s]). Star strains contain defective micronuclei
that do not contribute meiotic products in the cross and therefore result in
endoduplication of the haploid genome from the heterozygous micronuclear knockout
strain and generation of a homozygous knockout MIC genome. Star crosses do not
complete conjugation, they maintain their parental MAC and the progeny of the Star
parent contains a wild-type MAC with a homozygous knockout MIC. BVI and BVII
ΔUBC9 germ line-knockout heterokaryons were crossed to obtain progeny that are
complete ΔUBC9 homozygous homokaryon strains. These cells were used for phenotypic
analyses with the initially generated complete micronuclear and macronuclear knockout
lines described above. Elimination of the UBC9 gene was confirmed by genomic PCR
(Fig. 4C) and genetic crosses to wild-type strains (Fig. 5).
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Generation of Conditional UBC9 mutant line. The pGFP-UBC9 construct that inserts
adjacent to the Rpl29 locus was biolistically transformed [133] into mated heterokaryon
homozygous ΔUBC9 cells at 8 hours post-mixing. Transformed cells were selected with
12.5 µg/mL cycloheximide and induced with CdCl2 to initiate the expression of the GFPUBC9 fusion gene. The knock out heterokaryon parents of the cross have wild-type
paromomycin sensitive MACs. The cycloheximide resistant, GFP-Ubc9p progeny of the
cross were tested for paromomycin resistance to demonstrate successful mating and
generation of the new Ubc9p knock out MAC.
Isolating DNA, RNA and RT-PCR. Genomic DNA was isolated by Phenol: Chloroform
extraction followed by isopropanol as described previously [134]. Wild-type
Tetrahymena thermophila strains B2086 and conditional UBC9 KO strains were used for
isolation of total RNA using Qiagen RNeasy mini kit (Qiagen) supplemented by a
QIAshredder for cell homogenization. For RT-PCR, approximately 1 µg of RNA was
used for the first-strand cDNA synthesis (qScriptTM cDNA supermix, Quanta
Biosciences) using gene specific primers that amplify wild-type UBC9
(UBC9WT5’UTRF and UBC9WT5’UTRR shown in Table 1).
Fluorescence microscopy. Approximately 1 ml of vegetative or conjugating cells were
concentrated to 106 cells/ml by low speed centrifugation (1,100g), fixed for 30 minutes
with one volume of 4% paraformaldehyde, washed once in 10 X phosphate-buffered
saline (PBS, 1.37 M NaCl, 27 mM KCl, 100 mM Na2HPO4 and 18 mM KH2PO4) then
stained with DAPI at 1 µg/ml (4′, 6′-diamidino-2-phenylindole; 1 μg/ml) for 10 minutes.
Cells were then examined under fluorescence microscopy (Olympus BX51 TF model
microscope).
Growth rate test. Ubc9p conditional mutant strains were first cultured overnight in SPP
media with 0.1 µg/ml CdCl2 and then transferred to 10 ml SPP medium at a concentration
of 200 cells/ml in the presence or absence of 1 µg/ml CdCl2. Cell populations were
measured by direct cell counts at 0, 4, 8, 18, 24 and 48 hours using a hemocytometer.
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Drug sensitivity test. Ubc9p conditional mutant cells and wild-type B2086 cells were
cultured in SPP medium in the presence of 1.0 ug/ml CdCl2 or no CdCl2 for 24 h and
treated with 8 mM Methyl MethaneSulfonate (MMS) or 2 mM cisplatin for 2 hours
respectively and then washed twice with 10 mM Tris-Cl pH7.5. Single cells were isolated
into drops containing 0.5 µg/ml CdCl2. After 48 hours, the number of cells in each drop
was counted. Drops containing fewer than 10 cells were considered non-viable, drops
with more than 500 cells were considered viable.
Pairing efficiency test. UBC9 conditional mutants and wild-type were cultured in SPP
for 16 hours, harvested at 1,100 g, washed twice with 10 mM Tris pH7.5 and starved in
the presence of 0.05 µg/ml or no CdCl2 for 16-24 hours at 30 degrees. Two different
mating types were mixed (time 0) and samples of 200 µl were fixed with the addition of
200 µl 4% paraformaldehyde and counted for pairing efficiency. 100 cells were scored at
2, 4, 6, and 8 hours post-mixing. Pairing efficiency was calculated by counting the
number of mating pairs and multiplying by 2 (2 cells per pair) then dividing by the total
number of cells.
Table 1. Oligonucleotides used in this study.
Purpose

Name

Sequence

Knockout cassette

UBC9 5’flankF

GTCACTCGAGAGGAACCTATGCCGTATTAGATACA

UBC9 5’flankR
UBC9 3’flankF
UBC9 3’flankR

GACTAGATCTGTTTAAATAAATAAGTAAGCAGGTAGCTGC
T
TTAGGGATCCGTAAGAGAATTTGCTGAAACCATG
ATTAGCGGCCGCAGCCTATTCGATCATTATTT

UBC9KOupstreamF

TTGTTATCCTTATGACCAAATTTTCTA

UBC9WTupstreamR
MTTpR

TGAGCCTAATATTGATAGTCCTGCT
TTTGCTAACCATAGCCAAAAT

RT-PCR assay of conditional lines

UBC9WT5’UTRF
UBC9WT5’UTRR
UBC9CodingF+start
UBC9CodingR-stop

TCAATTCAGATTCAGCGAAA
GCTGATTTCCAATCTTCTTCC
ATCGGGTACCATGTAGCAACAAAATA
ACTGGAATTCGTCTTTTTTTTTCATGGT

GFP-UBC9 construct

UBC9–startF
UBC9+stopR

CACCTAGCAACAAAATAAAGAAGTAAATGAATTAG
TCAGTCTTTTTTTTTCATGGTTTCAGCAAA

UBC9-mCherry construct

UBC9CodingF+start
UBC9CodingR-stop

ATCGGGTACCATGTAGCAACAAAATA
ACTGGAATTCGTCTTTTTTTTTCATGGT

UBC93'FlankF

ATCGGCGGCCGCAAAATTCACAAATTAAA

UBC93'FlankR

TGACGAGCTCAAAGGAGAGAACCAA

PCR to confirm knockout lines

22

Results
UBC9 is an essential gene. We identified a single UBC9 homolog in the Tetrahymena
genome. Searches of the Tetrahymena Genome Database
(http://ciliate.org/index.php/home/welcome/) with UBC9 orthologs from S. cerevisiae, S.
pombe and D.melanogaster revealed the same top Blast hit (TTHERM_00522720).
Reciprocal searches of the S. pombe and D. melanogaster genomes using the
Tetrahymena ortholog identified the corresponding UBC9 genes as the top Blast hits. The
Tetrahymena UBC9 deduced amino acid sequence has approximately 55% identity with
UBC9 orthologs from yeast and Drosophila. The deduced amino acid sequence contains
the conserved catalytic cysteine residue found in other Ubc9p proteins [135] and was
87% identical across the conserved catalytic domain (Fig. 3).

Figure 3. Sequence alignment of Ubc9 from different species. Dark shading represents
residues with high identify across all species. Light shading indicates less conserved
residues. The sequences and accession numbers of Ubc9p are as follows: H Sapiens,
NM_194261.2; M. musculus, NM_001177610.1; X. laevis, NM_001087289.1; D. rerio,
BC059506.1; D. melanogaster, AB017607.1; S. cerevisiae, Z74112.1; I. multifiliis,
XM_004034933.1; P. tetraurelia, XM_001430839.1; T. thermophila, GG662717.1.
Arrow is pointing to the cysteine active site residue.

Previous studies in budding yeast, nematodes, plants and mice have shown UBC9 is an
essential gene [13,48,136]. An exception is S. pombe wherein the deletion of hus5 (UBC9
homolog) causes severe mitotic defects and slow growth but cells can survive [35]. To
determine if UBC9 is essential in Tetrahymena, micronuclear (germline) UBC9 knockout
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cell lines were constructed. Sequences flanking UBC9 were amplified by PCR and cloned
into plasmid pMNBL, which contains a neomycin resistance gene (neo3) that is driven by
the inducible promoter from the metallothionein 1 gene (MTT1) (Fig.4A). The knockout
construct was introduced into Tetrahymena using standard biolistic transformation
procedures [134]. The transformed cells were selected for paromomycin resistance and
then crossed to a test strain to confirm germline integration. Finally the heterozygous
UBC9 deletion strains were mated with a star strain which contains a defective
micronucleus. This results in duplication of one of the haploid copies of the MIC genome
but these cells do not complete conjugation so they maintain a wild-type MAC. The
resulting cell lines are either wild-type (and investigated further) or homozygous knock
out heterokaryons with UBC9 deletions in the MIC but wild-type MACs (Fig. 4B).
Phenotypically these cell lines are paromomycin sensitive (wild-type MAC), but PCR
amplification generated the expected 481bp product derived from the neo3 insertion in
the MIC (Fig. 4C). Two homozygous ΔUBC9 heterokaryons cell lines were mated to
generate complete deletions in both the MIC and MAC in the daughter progeny.
Individual pairs were isolated and placed in drops with nutrient medium. The majority of
cells that survived conjugation subsequently died 8-9 cell divisions after mating (Fig. 5).
The remaining 19 drops contained live cells after 72 hours but these could results from a
failure to complete conjugation and form a new ΔUBC9 MAC. The drops were replicaplated to medium containing 6-methypurine in order to identify true exconjugants that
have successfully completed conjugation by exchanging genetic material and forming a
new MAC. All 19 drops were sensitive to 6-methylpurine which shows they are not
UBC9 complete deletions. This result demonstrates that the UBC9 gene is essential for
vegetative cell viability. Presumably cells survive for several fissions after conjugation
(with the formation of a new MAC) because Ubc9p from the parental cell is stable and is
gradually diluted to progeny cells. The results also demonstrate that there is no
requirement for expression of the UBC9 gene from the developing MAC to complete
conjugation.
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Fig. 4: Generation of UBC9 knock-out strain by homologous recombination in
Tetrahymena. (A) Sequences flanking UBC9 were PCR amplified and cloned into the
pMNBL plasmid [131].The plasmid was digested with NotI and XhoI to yield a fragment
capable of homologous recombination with the complementary sequence on the
chromosome. The shaded portion of the knockout construct represents the neomycin 3
cassette [131] that includes the neomycin resistance gene (NeoR) and metallothionein
promoter (MTTp). PCR primers used to assay integration of the NeoR cassette – one set
specific for the KO allele and the other specific for the wild-type allele – are shown. (B)
Schematic of the genetic cross to generate UBC9 knockout heterokaryon strains containing
homozygous UBC9 deletions in the micronucleus and a wild-type macronucleus. The
heterozygous ΔUBC9 cell line was crossed to a star strain resulting in a homozygous
micronuclear genome (see text for additional details). (C) PCR analysis of UBC9
heterokaryon strains. PCR amplification using the primers shown in panel A was followed by
separation of the products on an agarose. The homozygous heterokaryon UBC9 KO strains
generated a knockout product of 480 bp (lanes 5-8) despite a neomycin sensitive (wild-type
MAC) phenotype. The wild-type strains yielded only the 291 bp wild-type product as
expected (lanes 1-2).
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Fig. 5: Depletion of UBC9 is vegetative lethal. Complete deletion strains of UBC9
(MIC and MAC) were generated by mating two homozygous germ-line knockout
heterokaryon strains. All progeny of UBC9 deletion strains died approximately 8-9 cell
divisions after conjugation. Progeny of UBC9 heterokaryon knockout and wild-type cells
were viable and their successful conjugation confirmed by showing paromomycin
resistance.

Generation of a cell line with conditional Ubc9 expression. The lethal phenotype of
UBC9 complete deletion strains provided limited opportunities for the molecular analysis
of Ubc9p function. To circumvent this problem we created a cell line with conditional
expression of Ubc9p. The strategy involved mating UBC9 homozygous heterokaryons
strains and then transforming those cells with a green fluorescent protein GFP-UBC9
fusion gene regulated by the Tetrahymena thermophila metallothionein 1 gene promoter
(Fig. 6A). The GFP-UBC9 transgene was introduced into the progeny of mated
homozygous heterokaryon Tetrahymena at 8 hours post-mixing when cells begin to
generate new MACs. Insertion of transgene into the Rpl29 locus in anlagen confers
cycloheximide resistance [137]. Transformants were selected with cycloheximide and
induced with CdCl2 to initiate the expression of the GFP-UBC9 fusion gene. The
resulting cell lines were GFP positive and paromomycin resistant as expected for the
progeny of the homozygous heterokaryon parents. As predicted by Ubc9p localization in
other species, we observed nuclear localization when cells were grown in the presence of
CdCl2 (Fig. 6B, middle and right panel). In order to verify GFP-UBC9 CdCl2-dependent
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regulation, conditional mutants were grown in the medium without CdCl2 and in the
presence of two different concentrations of CdCl2. Cells were fixed with 4%
paraformaldehyde and examined using fluorescent microscopy. As shown in Figure 6B
(left panel) no fluorescence signal can be detected in the cells cultured without CdCl2,
consistent with the low level of MTT promoter activity in the absence of heavy metal.
On the other hand, an increasing fluorescent signal was observed in the nucleus when the
cells were cultured in 0.1 mg/ml or 1.0 mg/ml CdCl2 (Fig. 6B, middle and right panel).
RT-PCR was carried out to confirm the transcript of UBC9. Two sets of primers were
designed and indicated in schematic drawing (Fig. 6C). The first set was used to detect
UBC9 transcript at endogenous locus. One primers was in 5’ UTR of endogenous UBC9
and the other primer was inside UBC9 coding region (Fig. 6C, indicated by arrow heads).
The second set of primer was used to detect UBC9 coding region, where both primers are
inside UBC9 (Fig 6C, indicated by arrows). The band corresponding to endogenous
UBC9 was only observed in wild-type Tetrahymena and was not present in ΔUBC9
conditional mutants (Fig. 6D, first panel). On the other hand, bands corresponding to
UBC9 coding regions were detected in both wild-type and conditional mutants (Fig. 6D,
second panel), which demonstrates that ΔUBC9 conditional mutants express only the
GFP-UBC9 form and not wild-type UBC9. We therefore conclude that a conditional
CdCl2-dependent UBC9 expression strain was generated.
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Fig. 6: Generation of conditional UBC9 knockout cell lines. (A) Schematic drawing of
the approach used to generate a conditional GFP-UBC9 expressing strain. Heterokaryons
homozygous UBC9 deletion cells of different mating types were mixed. GFP-UBC9
construct was biolistically transformed into mated cells at 8 hours post-mixing. (B) The
expression of GFP-Ubc9p is regulated by CdCl2. The conditional GFP-Ubc9p strains
were grown in the SPP medium supplemented with different concentrations of CdCl2.
Cells were fixed, stained with DAPI and viewed by fluorescence microscopy using 10x
objective. Exposure times were identical for all pictures. (C, D) RT-PCR was used to
confirm that endogenous UBC9 transcript cannot be detected in conditional mutants. The
location of the primers used to amplify regions from cDNA are shown (C). One set of
primer was used to assay UBC9 transcript at its endogenous locus. One primer is located
in UBC9 5’ UTR and the other one is located inside UBC9 (Showing in arrow head). A
second set of primer was used to assay UBC9 coding region (showing in arrows). (D)
Endogenous UBC9 transcript was only detected in wild-type strain but not conditional
mutants, while UBC9 coding region was present in both wild-type and conditional
mutants.

Depletion of UBC9 leads to reduced cell growth and nuclear defects. In other species
Ubc9p has been shown to regulate many aspects of mitosis, including chromosome
segregation, cell cycle progression [35,39,138]. We made use of our ΔUBC9 conditional
cell lines to study the phenotypic effects of Ubc9p depletion in Tetrahymena during
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vegetative growth. To determine whether loss of Ubc9p affects Tetrahymena growth rate,
equal numbers of cells were inoculated into media with or without 1 µg/ml CdCl2 and
cells were counted at intervals of 4, 8, 18, 24 and 48 hours. As shown in Figure 7, the
ΔUBC9 conditional cells had a slower growth rate than the wild-type strain in the absence
of CdCl2. However, the same cell lines cultured in CdCl2 exhibited growth rates similar
to wild-type cells. Depletion of Ubc9p has been shown to cause chromosome missegregation. DAPI staining combined with florescent microscopy revealed that Ubc9p
depleted cells lost DAPI-detectable micronuclei (Fig. 8A, middle panel). Conditional
mutants cultured with or without CdCl2, as well as wild-type cells, were isolated after 24
hours. The number of micronuclei were counted and summarized (Fig. 8B). In the UBC9
depleted cells, nearly half of the cells contained no DAPI-detectable micronuclei. For
those cells with MICs, division often involved with unequal partitioning of DNA to
daughter nuclei (Fig. 8C). This is consistent with defects in separation of sister
chromatids. Unlike most eukaryotes, Tetrahymena does not require accurate chromosome
segregation during mitosis because they do not rely on the MIC for gene expression
during the vegetative life cycle. Cells can be maintained indefinitely with micronuclear
aneuploidy. Surprisingly, we observed an increase in the number of cells having more
than two MICs when medium is supplemented with CdCl2. One possible explanation was
that over expression of Ubc9p has a dominant negative effect due to increased Ubc9p
activity. In order to test this hypothesis, we generated a cell line expressing a catalytically
inactive Ubc9p (DN-Ubc9p) due to a point mutation that changes the active site cysteine
(C100) to a serine. To reduce the wild-type copy of Ubc9, we also disrupted the wildtype UBC9 gene by introducing the pUBC9KO plasmid used for the construction of the
micronuclear knockout into the DN-Ubc9p cell line. These cells should have decreased
expression of catalytically active Ubc9p, yet rather than lacking micronuclei they contain
multiple MICs (Fig. 9).
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Fig. 7: Growth curve of UBC9 depletion strain. ΔUBC9 conditional mutants and wildtype cells were inoculated into 10 ml of SPP medium at a concentration of 200 cells/ml in
either presence or absence of CdCl2. Cell populations were measure by direct cell counts
at 0, 4, 8, 18, 24 and 48 hours. Cell numbers were plotted by strains in the presence or
absence of CdCl2. Solid line with solid square represents conditional mutant with CdCl2,
solid line with empty square represents conditional mutants without CdCl2, dash line with
solid circle represents wild-type with CdCl2, and dash line with empty circle represents
wild-type without CdCl2.
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Fig. 8: Depletion of Ubc9p causes instability of nuclei. The ΔUBC9 conditional
mutants were cultured in SPP medium in the presence or absence of 1 CdCl2 for 24 hours
along with wild-type cells in the absence of CdCl2 (A) Cells sampled after 24 hours of
culture in the different conditions were fixed with 4% paraformaldehyde and stained with
DAPI then viewed with a 40x objective under fluorescence. Representative images shows
that ΔUBC9 conditional cells cultured in the absence of CdCl2 lost micronuclei but
samples from the same cell lines in the presence of CdCl2 contained at least one
micronucleus. (B) The numbers of micronuclei were scored and summarized in the pie
chart. 100 cells from each condition were scored and characterized into three subsets,
cells with no MIC, cells with 1 MIC and cells with 2 or more MICs. (C) Ubc9p is
required for proper chromosome segregation. Wild-type or ΔUBC9 conditional mutants
cultured in 1.0 µg/ml or no CdCl2 were fixed and stained with DAPI. Examples of
dividing cells (Panel C, a and b) were selected to illustrate nuclear division in each
condition. Arrows indicate MICs.
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Fig. 9: Cells expressing dominant negative Ubc9 have multiple micronuclei. DNUBC9-KO cells were grown in 1 x SPP in the presence of 1 µg/ml CdCl2 for 16 hours.
(A) Samples were fixed and stained with DAPI and viewed with 40x objective. Large
numbers of cells had multiple micronuclei (Top left panel). (B) For each culture 100 cells
were scored for the numbers of micronuclei and are summarized in the pie chart (B).
More than 85% of cells have MIC number greater than 2, only 13% have 1 MIC.
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Depletion of Ubc9p results in hypersensitivity to DNA damaging agents. A role for
SUMOylation in DNA damage repair, especially in response to double-strand breaks has
been established in mammalian species and yeast [53,63,76,139,140]. To evaluate
whether Ubc9p is involved in DNA damage repair in Tetrahymena, we tested the effect
of DNA-damaging agents MMS and cisplatin on ΔUBC9 conditional mutants. ΔUBC9
conditional mutants and wild-type cells were cultured separately in SPP medium
containing 1 µg/ml CdCl2 or no CdCl2. Cells were treated with 8 mM MMS or 2 mM
cisplatin for 2 hours then washed twice with 10 mM Tris pH7.5. Single cells were placed
into drops (approximately 15 µl) of SPP containing 0.5 µg/ml CdCl2. The CdCl2 in the
post-treatment drops provides conditions that are optimal for growth of conditional cell
lines and at a disadvantage without cadmium (Fig. 7). After 48 hours the cells in each
drop were scored as viable if greater as 500 cells were in a drop and nonviable if there
were 0-10 cells. No drops had cell numbers between 10 and 500. As shown in Figure 10,
ΔUbc9 conditional cells cultured in the absence of CdCl2 show only 12% survival in
MMS compared with 90% survival when cultured with CdCl2. Survival in cisplatin rises
roughly 15 fold (5% vs 80%) in the presence of cadmium. Wild- type cells show little
change in sensitivity regardless of the presence or absence of CdCl2 (Fig. 10). This is
consistent with a role of Ubc9p and SUMOylation in DNA break repair.
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Fig. 10: Depletion of Ubc9p results in hypersensitivity to DNA damaging agents.
UBC9 conditional mutant strains were grown in 1 x SPP medium in the presence or
absence of 1 µg/ml CdCl2 for 24 h. Cells were treated with 8 mM MMS or 2 mM
cisplatin for 2 hours and then washed twice with 10 mM Tris-Cl pH7.5. 80 single cells
were isolated to drops with growth medium in the presence of 0.5 µg/ml CdCl2 and
incubated for 48 hours. Drops containing more than 500 cells were scored as viable, and
drops containing fewer than 10 cells were counted as nonviable. Viability is expressed as
the percentage of viable drops out of the total.

Ubc9p localizes to developing macronuclei. Tetrahymena conjugation is a dynamic
process, involving meiosis, selection of one meiotic product, formation of the diploid
zygotic nucleus, two rounds of post zygotic mitosis and macronuclear development. To
establish the location of Ubc9p during these nuclear event, we generated Tetrahymena
cell lines in which a UBC9-mcherry transgene is driven by the endogenous UBC9
promoter. Cells were prepared for mating by overnight log phase culture then starvation
in 10 mM Tris pH 7.5 for 16- 24 hours. Cell samples were taken before mixing and at
various time points after mixing, then fixed and stained with DAPI and observed using a
fluorescence microscope. Wild-type cells without a mcherry tag were used as controls. A
faint signal was observed in the macronucleus of starved cells indicating the low
expression of Ubc9p during starvation (Fig. 11, starvation). During meiosis, the signal
was exclusively observed in the parental macronuclei during the pronuclear exchange
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stage and post-zygotic division stage (Fig 11, T=3-6). At 8 hour post-mixing, the signal
was accumulated in the developing MAC (Fig. 11, T=8). The data indicates increased
expression of Ubc9p during conjugation and the majority of Ubc9p accumulates in the
developing macronucleus, the site of developmentally regulated genome reorganization.

Fig. 11: Localization of Ubc9 during conjugation. Ubc9 was tagged with mCherry on
the C-terminus at its endogenous locus. Cells were fixed with 4% paraformaldehyde and
stained with 1 µg/µl DAPI and viewed by a 40x objective under fluorescent microscope.
The following developmental stage are observed: a. Prophase meiosis I (T=3 hrs); b.
Zygotic nuclei (T=4 hrs); c. postzygotic division (T=6hrs); d. formation of developing
macronuclei (T=8 hrs).
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Ubc9 is required for pair formation in conjugating Tetrahymena. The localization of
Ubc9-mcherry to the developing macronucleus suggested a role in conjugation,
consequently we mated our Ubc9p depleted cell lines to assay for a conjugation defective
phenotype. ΔUBC9 conditional mutants of different mating types were cultured overnight
in SPP medium with or without CdCl2 to promote or reduce expression of the GFPUBC9 transgene. Cells were washed twice in 10 mM Tris pH7.5 and cultured in the same
media plus (+Cd) or minus CdCl2 (-Cd). Wild-type cells served as controls and were
treated with the same conditions. The ΔUBC9 conditional cells from non-CdCl2 treated
cultures (Ubc9 depleted) were mixed to initiate mating. Separate cultures of CdCl2treated Ubc9p conditional lines or wild-type cells were also mixed to initiate cell pairing.
Cells were evaluated at 2, 4, 6, and 8 hours post-mixing for pair formation. As shown in
Figure 12, Ubc9p conditional mutant cultures that were not exposed to CdCl2 (Ubc9pdepleted) were unable to form mating pairs at two hours post-mixing and only formed 10
% pairs after 8 hours, well past the standard 2 hour pairing period. In contrast, the same
cell line supplemented with CdCl2 was able to generate 40-60% mating pairs. Wild-type
cells exhibited pairing efficiencies >90%. Although the conditional cell lines cultures
with CdCl2 did not pair as well as wild-type cells (59% versus 82% at 8 hours), the
difference between +CdCl2 and -CdCl2 was much larger (59% versus 4%). We
consistently observe a slight loss of pairing efficiency when wild-type cells are exposed
to CdCl2 (see Figure 12) so a large increase upon exposure to CdCl2 is particularly
significant. In addition to Ubc9p effects on pairing, other experiments in the Forney lab
show a pairing defect for Uba2 and Smt3 (SUMO) depleted cell lines (A. Nasir and J.
Forney, manualscript in press). Cells expressing the dominant negative Ubc9p showed
normal pairing regardless of CdCl2 treatment (data not shown).
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Fig. 12: Depletion of Ubc9p results in reduced pairing. ΔUBC9 conditional mutants
were grown and starved in the presence and absence of CdCl2 and mixed. After fixation,
100 cells were scored for mating efficiency at 2, 4, 6, 8 hours post-mixing. CdCl2depleted cells were unable to from mating pairs. Light blue bar represents wild-type cells
supplemented with CdCl2, dark blue bar represents wild-type cells without CdCl2; Pink
bar represents ΔUBC9 conditional mutants with CdCl2 and red bar represents ΔUBC9
conditional mutants without CdCl2.

Reduced expression of UBC9 results in delayed meiosis. The inability of Ubc9p
depleted cells to form pairs prevented the analysis of later stages during conjugation. As
an alternative approach, we decided to mate ΔUBC9 conditional mutants to wild-type
cells and examine the cells for defects during conjugation. ΔUBC9 conditional mutant
cells were cultured in the presence and absence of CdCl2 and starved as described in the
previous experiment. They were mated to wild-type cells that were cultured without
CdCl2. Paired cells were examined 8 hours post-mixing to check for the progression
through conjugation. Each pair was placed into one of four categories based on DAPI
stained nuclei. At 2-3 hours wild-type cells are expected at the crescent micronucleus
stage (meiotic prophase) followed by prezygotic mitosis, 2nd post-zygotic nuclear
division and MAC differentiation (expected at 8 hours). Wild- type cells progressed
through conjugation normally and were primarily in the macronuclear differentiation
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stage as expected (Fig. 13). ΔUBC9 conditional mutants cultured in CdCl2 were slightly
delayed with 63% of the cells in the second post-zygotic stage and 18% of cells in
macronuclear differentiation stage. In stark contrast, for conditional mutants in the
absence of CdCl2 41% of pairs were in meiotic prophase and 28% were in pre-zygotic
nuclear division stage in their progression through conjugation. Eventually, these cells
progressed through conjugation which may be attributed to the expression of Ubc9p from
the wild-type partner.
Although the ΔUBC9 conditional lines mated to wild-type cells provide some evidence
for stalling at meiosis, the cell lines may accumulate micronuclear genome defects that
make it difficult use a genetic assay to test for successful conjugation. We examined
matings between cells expressing the previously described dominant negative-Ubc9 (DNUbc9) as an alternative approach. When DN-Ubc9p cells were cultured in the presence of
CdCl2 (inducing expression of DN-Ubc9p) and then mated to each other 32% of mating
pairs were in the meiotic prophase stage and 51% were at pre- or post-zygotic division
stage at 8 hours when wild-type cells were in the MAC differentiation stage (data not
shown). Since these cells were only exposed to CdCl2 immediately before mating the
progeny were scored for successful conjugation by treating them with 6-methylpurine (6MP). The parental strains have the 6-MP resistance gene in the mic but not the MAC.
Progeny that successfully completed conjugation and form a new MAC are 6-MP
resistance. . Although there is variation in the frequency of successful conjugation
between different transformants the cell lines expressing the dominant negative Ubc9p
display reduced conjugation efficiency relative to the same cell lines without CdCl2.
(Table 2). 35% of the cells expressing DN-Ubc9p arrested at macronuclear development
stage (Fig.14). Both sets of genetics crosses, cells with depletion of Ubc9p and cells with
excess catalytically defective Ubc9p (DN-Ubc9), have defects in conjugation and point
toward a role in meiosis.
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Figure 13: Reduced expression of Ubc9 leads to stall in meiosis. ΔUBC9 conditional
mutants were grown and starved in the presence of 1.0 µg/ml CdCl2 or no CdCl2 and
mixed with wild-type cells to initiate mating, respectively. Samples were fixed with 4%
paraformaldehyde and stained with DAPI at 8 hours post-mixing. 100 pairs were
examined under fluorescent microscope and divided into 4 groups based on the
progression in conjugation.
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Table 2: Expression of dominant negative Ubc9p reduces conjugation efficiency.

Figure 14: Tetrahymena cells expressing catalytic inactive Ubc9p arrested at
macronuclear development stage. DN-Ubc9p cells were grown and starved in the
presence of 1.0 µg/ml CdCl2 or no CdCl2 and mixed with wild-type cells to initiate
mating, respectively. Samples were fixed with 4% paraformaldehyde and stained with
DAPI at 24 hours post-mixing. 100 pairs were examined under fluorescent microscope
and divided into 3 groups based on the progression in conjugation.
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CHAPTER 3 IDENTIFICATION OF THE TETRAHYMENA THERMOPHILA
UBC9 INTERACTOME

Introduction
Ubc9 is the sole SUMO E2 enzyme and therefore interacts with the SUMO E1 complex
(Uba2p/Aos1p), potential E3s and protein targets of SUMOylation. The majority of the
Ubc9p interacting proteins have been discovered through yeast two-hybrid screening
[138,141-144]. Prudden et al revealed that Ubc9p regulates SUMOylation in distinct
cellular processes through noncovalent interaction [145]. In Tetrahymena, microarray
expression data shows upregulation in expression levels of SUMO pathway genes during
conjugation which suggest that SUMOylation may regulate cellular processes during this
stage of Tetrahymena development. Previous studies demonstrated that RNAi-induced
silencing of Uba2 and SUMO in Paramecium tetraurelia prevented the excision of IES
during formation of the somatic macronucleus [126]. This selective effect on DNA
elimination in the developing macronucleus suggests that SUMOylation is a key
regulator of this process. Here, I propose that Ubc9p regulates SUMOylation differently
during vegetative growth and conjugation in Tetrahymena by interacting with different
proteins. We anticipated major changes in the Ubc9p interacting proteins at different
stages of conjugation. Previous global analyses of SUMO substrates in S. cerevisiae
during vegetative growth have produced lists of Ubc9p interacting proteins [146],
however, there no published studies that document the spectrum of Ubc9p interacting
proteins between specific developmental settings.
To broaden our understanding of the function of SUMOylation in the Tetrahymena
sexual life cycle, we utilized a mass spectrometry-based identification of Ubc9p
interacting partners from vegetative and conjugating cell cultures. We found over 240
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direct Ubc9p interacting proteins during vegetative growth and more than 200 proteins
during conjugation. Among the identified Ubc9p interacting proteins are players in many
processes, including proteins involved in cell cycle control, chromosome remodeling,
ribosome biogenesis, RNA processing, transcription, translation and metabolism.
Materials and Methods
Plasmid construction. Tetrahymena thermophila Ubc9p was expressed with an Nterminal six histidine tag followed by a triple FLAG epitope tag and a short linker
(GGSG) (Fig. 14). The Tetrahymena (His)6-(FLAG)3-UBC9 was chemically synthesized
by IDT (Coralville, Iowa) and inserted into the BsiWI and ApaI sites of pBS-MTT-YFPgtw vector (Douglas Chalker, Washington University at St. Louis, MO) to generate
p(His)6-(FLAG)3-UBC9 plasmid. The plasmid contains the Tetrahymena CdCl2inducible MTT1 promoter upstream of the BsiWI insertion site. It also has flanking
sequences that guide homologous recombination into the rpl29 locus generating
cycloheximide-resistant Tetrahymena. Expression is induced by the addition of CdCl2.
Cell transformation and culture conditions. For biolistic transformation the p(His)6(FLAG)3-UBC9 plasmid was digested with HindIII to generate a linear fragment with
flanking rpl29 sequences. Wild-type B2086 and CU428 Tetrahymena cells were
transformed as described in Chapter 2 using previously published methods [133]. Cells
were selected in SPP nutrient medium containing 12.5 μg/ml cycloheximide to identify
transformants. To induce (His)6-(FLAG)3-UBC9 expression, 0.1 μg/mL CdCl2 was
supplemented to cell cultures two hours prior to lysis. To generate samples from
conjugating cells two cultures of different mating types were grown overnight in SPP
media then washed and starved overnight in 10 mM Tris (pH 7.5). Approximately 500
mls of starved cells to an Abs540nm of 0.3 from each culture were mixed to induce mating.
They were treated with 0.05 ug/ml CdCl2 at 6 hours then harvested and lysed at 8 hours
post-mixing. The samples were processed using the same procedure for tandem affinity
purification described below.
Affinity purification. The (His)6-(FLAG)3-UBC9 containing Tetrahymena strain was
grown to an Abs540nm of 0.3 in 1 liter of SPP media at 30 °C. The cells were washed once
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with 10 mM Tris-HCl (pH 7.5) and lysed in 10 ml Native lysis buffer (150 mM NaCI, 50
mM Tris, 10% Glycerol, 10 mM beta-mercaptoethanol (βME), 1 mM Imidazole, 0.2%
IGEPAL CA-630 (Sigma, Inc.) pH7.5, with addition of 50 mM NEM and protease
inhibitors (1 µg/ml E-64, 5 µg/ml antipain, 5 µg/ml leupeptin, 6 µg/ml chymostatin). The
cell suspension was lysed by sonication (50 pulses at setting 7 with 50% output using
Misonix XL-2015 sonicator) and clarified by centrifugation at 25,000 rpm in a Beckman
SW41 Ti rotor for 50 minutes at 4o C. Ten mls of supernatant was incubated with 500 µl
of Ni-NTA agarose (Qiagen, Valencia, CA) overnight at 4 °C with gentle rotation. Beads
were washed three times with 10 ml of wash buffer for 15 minutes (150 mM NaCI, 50
mM Tris, 10 mM Imidazole, pH 7.5) at 4o C. After each wash the beads were collected at
500 rpm for 3 minutes using J2-MC Backman Coulter High-performance centrifuge. The
beads were eluted twice with total 10 ml of elution buffer (150 mM NaCI, 50 mM Tris,
250 mM Imidazole, pH 7.5). The elution fractions were pooled and incubated with 200 µl
anti-FLAG affinity resin (Genscript, Piscataway, NJ) for 1 hour at 4 °C. Beads were
washed three times with 10 ml TBS buffer (50 mM Tris-Cl, pH7.5, 150 mM NaCl) and
collected by centrifugation at 500 rpm for 1 minute. Samples were eluted with 1 ml of
3xFLAG peptide (Sigma, St. Louis, MO) at a final concentration of 100 µg/ml in TBS.
The final elution was subjected to Trichloroacetic acid (TCA) precipitation. Briefly, 1
volume of 100% TCA was added to 4 volumes of protein sample followed by incubation
at 4 ° C for 10 min. Samples were spun in bench top microcentrifuge (Eppendorf
centrifuge 5424) at 14K rpm for 5 min to collect pellets, which were further washed twice
with 200 µl cold acetone. Pellets were air dried and re-suspended in 4 x loading buffer
(200 mM Tris-Cl pH6.8, 8% SDS, 0.4 % bromophenol blue and 40% glycerol)
supplemented with 100 mM dithiothreitol (DTT). Samples were incubated for 5 min in
95 °C heating block before loading onto a polyacrylamide gel.
Western analysis. Affinity purified protein samples were loaded proportionally onto
10% polyacrylamide gels for SDS-PAGE analysis. Gels were blotted onto polyvinylidene
difluoride (PVDF) membranes, which were further blocked in 5% skim milk in PBST
(0.1% (v/v) Tween 20 in 1x PBS) for 3 hours and incubated with affinity-purified antiFLAG antibody (Sigma Inc, 1:10,000 dilution in 5% skim milk in PBST) for 16 hours.
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Blots were washed 3 three, 15 minutes each at room temperature with PBST. Secondary
horseradish peroxidase-conjugated Goat anti-monse lgG antibody (Jackson
ImmunoResearch, West Grove, PA) was used at 1: 10,000 dilution followed by washing
as before and detection by Luminata Crescendo Western HRP substrate (Millipore,
Darmstadt, Germany) according to manufacture direction.. Blots were typically exposed
for 30s using ChemiDocTM XRS+ gel imaging system (Bio-Rad, Hercules, California).
In gel trypsin digestion and protein fractionation. Final purified protein samples were
separated on 12 % SDS-PAGE and stained with Coomassie Blue R-250. Each lane was
cut into 5 to 6 small pieces and each piece was transferred into a 1.8 ml low-binding tube
(Axygen Maxymum Recovery) with 100 µl HPLC-grade H2O. Tubes were incubated at
room temperature for 10 minutes with gentle shaking. Samples are then washed twice
with 100 µl freshly made 25 mM ammonium bicarbonate in 50% acetonitrile and
incubated for 10 minutes with shaking. The final wash was performed with 100%
acetonitrile for 10 minutes. 100% acetonitrile was removed and followed by trypsin
digestion at a concentration of 20 µg/ml in 50 mM ammonium bicarbonate overnight at
37 °C. The tryptic digestion was extracted three time with 50 µl 100% acetonitrile and
quenched by adding trifluoroacetic acid (TFA) to a concentration of 0.1%, followed by
C18 column cleanup.
LC-MS Sample Acquisition and database search. A commercial 5600 TripleTOFTM
(ABSciex, Concord, Canada) was used for all the experiments. The instrument was
coupled with an Eksigent NanoLC-2DPlus with nanoFlex cHiPLC (Eksigent, Dublin,
CA) system. The solvents used were as follows: solvent A: composed of 0.1% (v/v)
formic acid in water and solvent B: 95% (v/v) acetonitrile with 0.1% (v/v) formic acid.
The sample acquisitions were performed using a “trap and elute” configuration on the
nanoFlex system. The trap column (200 m 0.5 mm) and the analytical column (75 m 15
cm) were packed with 3 m ChromXP C18 medium. Samples were loaded at a flow rate of
2 nl/min for 10 min and eluted from the analytical column at a flow rate of 300 nl/min in
a linear gradient of 5% solvent B to 35% solvent B in 90 min. The column was
regenerated by washing with 80% solvent B for 10 min and re-equilibrated with 5%
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solvent B for 10 min. For standard data-dependent analysis experiments, the mass
spectrometer was operated in a manner where a 250-ms survey scan (TOF-MS) was
collected, from which the top 50 ions were selected for automated MS/MS in subsequent
experiments where each MS/MS event consisted of a 50-ms scan. The selection criteria
for parent ions included intensity, where ions had to be greater than 100 counts/s with a
charge state between 2 to 4 and were not present on the dynamic exclusion list. Once an
ion had been fragmented by MS/MS, its mass and isotopes were excluded for a period of
6 s. Ions were isolated using a quadrupole resolution of 0.7 Da and fragmented in the
collision cell using collision energy ramped from 15 to 45 eV within the 50-ms
accumulation time. In the instances where there were less than 20 parent ions that met the
selection criteria, those ions that did were subjected to longer accumulation times to
maintain a constant total cycle time.
The Mascot database search analysis for the reference peptide of the dilution series was
performed on Mascot v. 2.5. The enzyme selected was trypsin with 2 missed cleavages. A
search tolerance of 20 ppm was specified for the peptide mass tolerance and 0.2 Da for
the MS/MS tolerance. The charges of the peptides to search for were set to 2, 3, and 4.
The search was set on monoisotopic mass and the instrument configuration was set to
ESI-QUADTOF. No variable or fixed modifications were used. The spectra were
searched against a reverse database to estimate the false discovery rate. Peptides were
filtered to an FDR of 1% and proteins were required to have 2 or more peptides identified
at the 1% FDR level.
Results
Isolation of SUMO conjugates during Tetrahymena vegetative growth and
conjugation. We adopted a scheme that involved a two-step affinity- purification
strategy using N-terminal tagged Ubc9p with both (His)6 and (FLAG)3 tags (Fig. 15),
followed by tandem mass spectrometry-based protein identification of trypsin-digested
proteins. As a control, wild-type Tetrahymena lacking tagged Ubc9p were collected and
processed under identical conditions. In the first step of the two-step affinity purification,
the (His)6 tag was bound to nickel-coupled agarose under native conditions in order to
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preserve non-covalent protein complexes that interact with Ubc9. To achieve a higher
degree of purification, a second affinity purification step employing anti-FLAG
antibodies was carried out. Immunoblotting probed with FLAG antibody confirmed the
tagged Ubc9p signal did not exist in control sample (Fig. 16). Coomassie Blue staining of
a SDS-polyacrylamide gel with samples purified from vegetative and conjugating
containing dual-tagged Ubc9p and from untagged negative control, demonstrated very
few proteins in the control sample (Fig. 17). The Coomassie stained SDS-PAGE gel lanes
containing the experimental and control samples were each cut into 7 equal-size slices,
followed by in-gel trypsin digestion and subsequent analysis by LC-MS/MS. Three
biological replicates were conducted with vegetative samples and two for conjugating
samples.

Fig. 15: Schematic drawing of dual tagged UBC9. UBC9 was N-terminal tagged with
(His)6, followed by (FLAG)3. Two small linkers were inserted in this construct to
increase the flexibility. One was Alanine that was inserted between His tag and FLAG
tag. The other one (GGSG) was inserted between FLAG tag and UBC9 gene. This
construct is driven by the metallothionein promoter (MTTp) that can be induced by
CaCl2. Codons were optimized for expression in Tetrahymena usage. Construct was
chemically synthesized by IDT (Coralville, Iowa) and inserted into the BsiWI and ApaI
sites of pBS-MTT-YFP-gtw vector (Douglas Chalker, Washington University at St.
Louis, MO) to create p(His)6-(FLAG)3-UBC9 plasmid.
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Fig. 16: Purification of Ubc9 interacting proteins from vegetative and mated
Tetrahymena cells. Samples were collected after each step during purification, for both
the Ni-NTA and FLAG purifications including whole cell extract (input), flow through
and elution. Samples were loaded proportionally and resolved by SDS-PAGE (10% gel).
Top: Fractions from vegetative growth. Lane 1 contains proteins from the tagged Ubc9p
strain and lane 2 contains protein from is the untagged wild type cell control; lane 3 and 4
are flow through from Ni-NTA agarose purification of tagged and untagged strains; lane
5 and 6 are elution from Ni-NTA agarose purification of tagged and untagged strains;
lane 7 is marker; lane 8 is flow through from anti-FLAG resin of tagged strain; lane 9 and
10 are elution from anti-FLAG resin purification of tagged and untagged strains. Bottom:
Fractions from mated samples. Lane 1 contains proteins from the tagged Ubc9p strain
and lane 2 contains protein from is the untagged wild type cell control; lane 3 is flow
through from Ni-NTA agarose purification of tagged strains; lane 4 and 5 are elution
from Ni-NTA agarose purification of tagged and untagged strains; lane 6 is marker; lane
7 is flow through from anti-FLAG resin of tagged strain; lane 8 and 9 are elution from
anti-FLAG resin purification of tagged and untagged strains.
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Fig. 17: Coomassie stained gels ofing affinity purified fractions. (His)6-(FLAG)3Ubc9 cell lines and untagged control strains were induced with cadmium and then lysed
under native conditions. The clarified lysates were used for two rounds of affinity
purification, first with Ni-NTA resin and then anti-FLAG resin. Final elutes were
separated by SDS-PAGE (12% gel) and stained with Coomassie blue. Left: Purified
proteins from vegetative cells after elution from the second affinity resin and
concentration by TCA precipitation. Lane 1 contains proteins from the tagged Ubc9p
strain and lane 2 contains protein from is the untagged wild type cell control. Right:
Proteins from mated cell purifications. Lane 1 and 2 are input of strains with tagged
protein and untagged; lane 3 and 4 are elution from Ni-NTA agarose purification of
tagged and untagged strains; lane 5 is marker; lane 6 and 7 are elution from FLAG resin
puridication of tagged and untagged strains.

LC-MS/MS data were analyzed using mascot to search the database of known
Tetrahymena proteins sequences. A total of 242 proteins were uniquely found in
vegetative samples expressing tagged-Ubc9 and 213 were uniquely found in conjugating
samples. In addition to a large number of novel Ubc9p interacting proteins identified, the
list includes orthologous of previously identified Ubc9p interacting protein or SUMO
conjugates in other organisms (e.g. Cdc2, TopI, EEF2, DRH19, multiple aminoacyltRNA synthetases and ribosomal proteins) [146,147].
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Evaluation of Ubc9 interacting proteins found through global MS analysis. To our
surprise, there are large numbers of metabolic proteins were identified in our affinity
purifications. Many of the same proteins showed up in yeast SUMO purification too
(personal communication with Dr. Mark Hochstrasser, Yale University). Highly abundant
proteins complicate the data set as they stick to the epitope tags but are not
physiologically significant Ubc9p interacting partners. In order to increase our
confidence in the list of Ubc9p interacting proteins, we compared the proteins on our lists
to those identified from two other published unrelated Tetrahymena purifications. In one
study mitochondria were purified and proteins were identified by mass spectrometry. In
the other study, the outer pellicle, which is the scaffold for outer membrane structure, was
purified and proteins identified [148,149]. Proteins that appeared in all three purifications
works (mitochondria, pellicle and Ubc9) were are subtracted from our lists, which
resulted in new lists with proteins of higher confidence. Those so-called “junk proteins”
are summarized in Table 6. After the subtraction of these common proteins, our list
contained 128 proteins that we have higher confidence direct interact with Ubc9p during
Tetrahymena vegetative growth (Table 3) and 106 proteins during conjugation (Table 4).
These two data sets are categorized based on their functions (Fig. 18), including cell
cycle regulation, RNA processing, gene transcription, chromatin remodeling and stress
response. The cell cycle proteins that we identified include TopoI, which has been
previously identified as a SUMO substrate, and CDC2, homolog of which has been
identified as Ubc9p interacting protein in yeast [146]. Our goal is to identify conjugationspecific Ubc9p interacting proteins and we anticipate that some of these will be identified
as SUMO substrates. We compared the Ubc9p interacting protein list from vegetative and
conjugating cell culture and found 48 proteins that were common which means that there
were 58 proteins that are specific to conjugation (Fig. 19 and Table 5). These proteins
include Twi 1 which is an argonaute protein that is required for IES excision during
macronuclear development [119]. The other example is High Mobility Group B protein
(HMGB) that is involved in genetic exchange during conjugation [148].
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Fig. 18: Graphical representation of functional categories of Ubc9 and SUMO
interacting partners in both vegetative and mated cells. Proteins that were identified
were categorized into different subsets based on their biological functions. The uniprot
knowledgebase and Tetrahymena Genome Database (TGD) were both used to graphically
display the biological functions of Ubc9p interacting proteins in (A) vegetative cells, (B)
mated cells. As expected, a high number of proteins responsible for ribosome biogenesis
were identified. The largest category of these proteins are involved in metabolic
processes. However, SUMOylation clearly regulates other key cellular processes such as
crosstalk with other protein translation modifications, response to cellular stimuli,
progression of the cell cycle and chromatin remodeling.
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Fig. 19: Overlap between Ubc9 interacting proteins in vegetative growth and
conjugation. There are 48 proteins that are present in purifications from both vegetative
growth and mated cells.

In 2013, Dr. Raught’s group identified 97 high-confidence Ubc9p interacting proteins
from S. cerevisiae using affinity purification followed by mass spectrometry approach
[146]. Four of these proteins were previously reported as Ubc9p interactors and 37 were
identified as SUMO conjugates. Again, we compared our Ubc9p list against their data set
and the majority of them were classified in the same functional category (Fig. 20). This
included 19% of proteins in metabolism in yeast compared with 27% in Tetrahymena,
surprisingly high fractions considering SUMOylation is considered primarily a
modification associated with nuclear proteins. It is possible that Ubc9p (and SUMO) has
a larger role in metabolism than currently recognized.
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Fig. 20: Graphical representation of biological processes of Ubc9p interacting
proteins in yeast. 97 high-confidence Ubc9p interacting proteins were reported by
Sirkumar et al. These proteins are categorized into different subsets based on their major
functions, including transcription, response to cellular environment, structure
maintenance, metabolism, cell division, chromatin remodeling, translation, transport, bud
site selection, ribosome biogenesis, RNA processing, PTM & degradation and unknown.

Table 3: Ubc9 interacting proteins identified from log phase vegetative cells
Gene Name

Standard Name

TTHERM_00194730

Description

Times
identified

hypothetical protein

1

TTHERM_00125640

SSA3 (HSP70a paralog)

dnaK protein

1

TTHERM_01080440*

SSA4 (HSP70a paralog)

dnaK protein

2

TTHERM_01044390* †

HSP71 (Heat Shock Protein )

Putative 70-kDa heat-shock protein (hsp70

2

TTHERM_00558440*†

SSA5 (HSP70a paralog)

dnaK protein

2

TTHERM_01435670

GLC3 (GLC3 Ortholog)

Alpha amylase, catalytic domain containing protein

1

TTHERM_00013700

hypothetical protein

1

TTHERM_01107480*

hypothetical protein

2

TTHERM_01287980*

hypothetical protein

3

TTHERM_00193410 *

serine hydroxymethyltransferase family protein

1

TTHERM_00318570*†

citrate synthase

1

TTHERM_00666180*†

conserved hypothetical protein

1

TTHERM_00535740†

Mitochondrial carrier protein

2

Mitochondrial carrier protein

1

TTHERM_00052470*†

AMP-binding enzyme family protein

2

TTHERM_00378560*

eukaryotic translation initiation factor 3 subunit 8

1

TTHERM_00429910*†

cytidyltransferase-related domain containing protein

2

TTHERM_00015980*

cytidyltransferase-related domain containing protein

1

TTHERM_00147510†

Coenzyme A transferase family protein

2

TTHERM_00535730

TTHERM_00497940*†
TTHERM_00433420*†

MCF2 (Mitochondrial carrier
family)

RRM34 (RNA recognition motifcontaining protein 34)

2
Protein kinase domain containing protein. Sequence similarity to the PKA protein
kinase family

1
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TTHERM_00658860*

Protein kinase domain containing protein. Sequence similarity to the PKA protein
kinase family

1

TTHERM_01014740*

hypothetical protein

2

TTHERM_00243730 *†

Glucosamine-6-phosphate isomerase/6-phosphogluconolactonase family protein

2

TTHERM_00402120 †

Glutathione S-transferase, N-terminal domain containing protein

2

XRN 5'-3' exonuclease N-terminus family protein

1

cyclic nucleotide-binding domain containing protein

1

Glyceraldehyde-3-phosphate dehydrogenase; metabolic enzyme involved in glycoloysis

1

TTHERM_00346560*†

Ubiquitin family protein

2

TTHERM_00085200*†

Ubiquitin family protein

3

TTHERM_00343440*†

conserved hypothetical protein

1

TTHERM_00569100

Thioredoxin family protein

2

TTHERM_00663830

XRN3 (5'-3' exoribonuclease 3)

TTHERM_00205180†
TTHERM_00551160 *†

TDH1 (glyceraldehyde-3phosphate dehydrogenase 1)

TTHERM_00467390

SOR3 (Sortilin 3)

BNR/Asp-box repeat family/ VPS10 domain containing protein

1

TTHERM_00636970 †

RPP0 (Ribosomal Protein P0 of
the large subunit)

Homolog of yeast RPP0, human RPLP0, bacteria RPL10; Acidic ribosomal protein P0
of the large subunit

1

TTHERM_00056140*†

ERS3 (glutaminyl-tRNA
synthetase 3)

glutaminyl-tRNA synthetase family protein

1

TTHERM_00773610

enoyl-CoA hydratase/isomerase family protein

2

TTHERM_00497380 *†

oxidoreductase, zinc-binding dehydrogenase family protein

1

TTHERM_00614859†

conserved hypothetical protein

1

TTHERM_00339700*†

hypothetical protein

1

TTHERM_00024200*

oxidoreductase, short chain dehydrogenase/reductase family protein

1

TTHERM_00024180

oxidoreductase, short chain dehydrogenase/reductase family protein

1

TTHERM_00024190*

oxidoreductase, short chain dehydrogenase/reductase family protein

1

TTHERM_00302100*

aminotransferase, classes I and II family protein

1
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TTHERM_00149340 *†

CCT2 (CCT2 Ortholog)

TCP-1/cpn60 chaperonin family protein

1

TTHERM_00522650*

DRH19 (DExD/H box RNA
helicase 19)

DEAD/DEAH box helicase family protein

1

Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein

1

60S ribosomal protein L9

1

TTHERM_00442880

Protein kinase domain containing protein. Sequence similarity to the ULK protein
kinase family

1

TTHERM_01084100 *†

Glutamine synthetase, catalytic domain containing protein

1

TTHERM_01250050

AMP-binding enzyme family protein

1

pyruvate kinase; converts phosphoenolpyruvate to pyruvate during glycolysis

1

TTHERM_00277470*

acetyl-CoA acyltransferases family protein

1

TTHERM_00836690 *†

Peptidase M16 inactive domain containing protein

2

hypothetical protein

1

cysteinyl-tRNA synthetase family protein

1

hypothetical protein

1

Formaldehyde dehydrogenase/S-formylglutathione hydrolase fusion protein; fusion
protein containing two enzymes known to catalyze sequential steps in the formaldehyde
detoxification pathway in yeast; this fusion unique to ciliates

2

hypothetical protein

1

phenylalanyl-tRNA synthetase, beta subunit family protein

1

TTHERM_00035180†

acetoacetate decarboxylase

1

TTHERM_00534010*

zinc finger protein, putative

2

TTHERM_00151390

ATP:guanido phosphotransferase, C-terminal catalytic domain containing protein

1

TTHERM_00813040

hypothetical protein

1

TTHERM_00670350

hypothetical protein

1

TTHERM_00444470 *†

S-adenosylmethionine synthetase family protein

2

TTHERM_01048110*†

TTHERM_00118600*†

PYK1 (PYruvate Kinase)

TTHERM_00426260*
TTHERM_00560000

CRS1 (cysteinyl-tRNA
synthetase 1)

TTHERM_01015930*
TTHERM_00295700*

FSF1 (Formaldehyde
dehydrogenase/Sformylglutathione hydrolase
fusion protein)

TTHERM_00753340
TTHERM_00218410

FRS2 (phenylalanyl-tRNA
synthetase 2)
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TTHERM_00954320*

Zinc finger, C2H2 type family protein

1

TTHERM_00388400†

hypothetical protein

2

TTHERM_00245120

hypothetical protein

1

TTHERM_00313119

predicted protein

1

phenylalanyl-tRNA synthetase, alpha subunit family protein

1

TTHERM_01194660*

translation elongation factor G

1

TTHERM_00052420

asparagine synthase

1

TTHERM_00787250

Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein

1

leucyl-tRNA synthetase family protein

1

TTHERM_00688570

Alanine racemase, N-terminal domain containing protein

1

TTHERM_00537300*†

ribose-phosphate pyrophosphokinase family protein

1

TTHERM_00681790*

hypothetical protein

1

Metabolic enzyme involved in triterpenoids biosynthesis; catalyzes the formation of
tetrahymanol from squalene by a direct cyclization.

1

TTHERM_00049060

hypothetical protein

1

TTHERM_00649120

ATP-dependent protease La family protein

1

TTHERM_00218270*

hypothetical protein

1

TTHERM_00499390*†

Glycine cleavage system T protein. Sequence similarity to the HisK protein kinase
family

2

TTHERM_00475310†

hypothetical protein

1

TTHERM_00300370

ABC transporter family protein

1

TTHERM_00077220

hypothetical protein

1

TTHERM_00348060*

Acyl-CoA oxidase family protein

1

TTHERM_00522760

ribose-phosphate pyrophosphokinase family protein

1

TTHERM_00133690†

TTHERM_00670340

TTHERM_01008630

FRS1 (phenylalanyl-tRNA
synthetase 1)

LRS1 ( leucyl-tRNA synthetase
1)

THC1 (Tetrahymanol cyclase)
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TTHERM_00773690†

adenylosuccinate synthetase family protein

1

TTHERM_00052020

ROK family protein

1

TTHERM_00028780

hypothetical protein

1

TTHERM_00023980†

Putative Ran GTPase; an evolutionarily conserved small GTPase with roles in nuclear
transport, mitotic spindle assembly and nuclear envelope assembly

2

TTHERM_00353480*†

HELP domain containing protein

1

TTHERM_00196200†

isocitrate dehydrogenase, NADP-dependent family protein

1

TTHERM_00377250

adenylosuccinate lyase family protein

1

Component of the Mcm2-7 complex involved in DNA replication

1

hypothetical protein

2

PUF2 (Pumilio-family protein 2)

Pumilio-family RNA binding repeat containing protein

1

TTHERM_00035580

preprotein translocase, SecY subunit containing protein

1

TTHERM_00292170

ERF1 (Eukaryotic Release Factor
)

Eukaryotic release factor 1; believed to recognize the stop codon of mRNA and
terminate translation; gene has 4 introns; deduced protein sequence 57% similar to
human eRF1; domain 1 proposed to be the codon recognition site

2

TTHERM_00448660†

hypothetical protein

1

TTHERM_00659131

conserved hypothetical protein

1

TTHERM_00077120

hypothetical protein

1

TTHERM_00312220
TTHERM_00442930*

nucleotide binding protein 2, putative
bZIP transcription factor family protein

1
1

TTHERM_00790780

Glycosyl transferase family, helical bundle domain containing protein

1

TTHERM_00195860†

Thiolase, N-terminal domain containing protein

1

TTHERM_00069420

RAN1 (RAN GTPase)

MCM5 (DNA replication
licensing factor MCM5)

TTHERM_00197760
TTHERM_00558490*

TTHERM_00526770

MYO13 (MYOsin )

TTHERM_01266070
TTHERM_00442210
TTHERM_00408760†

RPN2 (26S proteasome
regulatory subunit N2)

Myosin heavy chain; unclassisfied member of myosin protein family; not a member of
proposed myosin Class XX; contains predicted coiled-coil domains
protein phosphatase 2A regulatory B subunit (B56 family)

1
1

Proteasome/cyclosome repeat family protein

1

Ubiquitin carboxyl-terminal hydrolase family protein

1
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TTHERM_00382380†

AMP-binding enzyme family protein

1

TTHERM_01207690

hypothetical protein

1

malate dehydrogenase family protein

1

cyclic nucleotide-binding domain containing protein

1

RNA recognition motif-containing protein

2

Carboxyvinyl-carboxyphosphonate phosphorylmutase -related

1

Kelch motif family protein

1

TTHERM_01029960

MDH4 (malate dehydrogenase 4)

TTHERM_00697230
TTHERM_00421020*

RRM20 (RNA recognition motifcontaining protein 20)

TTHERM_00375130
TTHERM_00840140
TTHERM_00339620*†

RPL40 (Ribosomal Protein of the
Large Subunit #40)

TTHERM_00577080

PGM1 (PhosphoGlucoMutase )

TTHERM_00620980
TTHERM_00105430*†

PRF1 (PRoFilin)

TTHERM_00449180*
TTHERM_00522720†

UBC9 (Ubiquitin conjugating
enzyme 9)

TTHERM_00410130†

SMT3 (Suppressor of Mif Two )

TTHERM_00657560†
TTHERM_00190830†

DRH1 (DExD/H box RNA
helicase 1)

Homolog of Yeast RPL40; RPL40-Ubiquitin fusion protein; Ribosomal L40e family
protein
Phosphoglucomutase; carbohydrate metabolism enzyme that catalyzes the conversion
of alpha-D-glucose 1-phosphate into alpha-D-glucose 6-phosphate; knock-out mutants
have no defects in growth, morphology or exocytosis

2
1

hypothetical protein

1

Profilin family protein; both inhibits and enhances actin polymerization; co-localizes
with actin in the division furrow

1

hypothetical protein

1

SUMO-conjugating enzyme involved in the Smt3p conjugation pathway; a member of
the ubiquitin-conjugating enzyme E2 family
small ubiquitin-related modifier (SUMO), conjugated to lysine residues on target
proteins, post-translational modification,

1
1

hypothetical protein

1

P68-like protein, putative

1

TTHERM_00535260
succinyl-CoA synthetase, beta subunit family protein
TTHERM_00456860
hypothetical protein
* indicates the proteins that appeared in SUMO native purification
† indicated the proteins that appeared in Ubc9p native purification during conjugation

1
1
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Table 4: Ubc9 interacting proteins identified from 8-hour conjugating cells
Gene Name

Standard Name

Description

TTHERM_00522720†‡

UBC9 (Ubiquitin conjugating
enzyme 9)

TTHERM_00410130†‡

SMT3 (Suppressor of Mif Two )

TTHERM_00339620†

RPL40 (Ribosomal Protein of the
Large Subunit #40)

SUMO-conjugating enzyme involved in the Smt3p conjugation pathway; a member of
the ubiquitin-conjugating enzyme E2 family
small ubiquitin-related modifier (SUMO), conjugated to lysine residues on target
proteins, post-translational modification,
Homolog of Yeast RPL40; RPL40-Ubiquitin fusion protein; Ribosomal L40e family
protein

Times
identified
2
2
2

TTHERM_00346560†

Ubiquitin family protein

2

TTHERM_00085200†

Ubiquitin family protein

2

TTHERM_01006550

Thioredoxin family protein

1

Citrate synthase; bifunctional 14-nm filament-forming protein; structural protein
involved in oral morphogenesis and pronuclear behavior during conjugation; citrate
synthase activity decreased by polymerization and dephosphorylation

2

TTHERM_00622710‡

Pyridine nucleotide-disulphide oxidoreductase family protein

2

TTHERM_00655820

translation elongation factor EF-1, subunit alpha

2

TTHERM_00529790‡

CIT1 (CITrate synthase)

TTHERM_00191720‡

2

TTHERM_01044390†

HSP71 (Heat Shock Protein )

Putative 70-kDa heat-shock protein (hsp70);

2

TTHERM_00558440†‡

SSA5 (HSP70a paralog)

dnaK protein

1

TTHERM_00777260

hypothetical protein

2

TTHERM_01084110

Glutamine synthetase

2

TTHERM_00318570†

citrate synthase

2

TTHERM_00666180†

conserved hypothetical protein

2

TTHERM_00487140

hypothetical protein

1

TTHERM_00433420†

Protein kinase domain containing protein. Sequence similarity to the PKA protein kinase
family

2

14-3-3 protein

1

TTHERM_00160770

FTT49 (14-3-3 protein)
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TTHERM_00551160†

TDH1 (glyceraldehyde-3phosphate dehydrogenase 1)
RPL14 (Ribosomal protein of the
large subunit)

Glyceraldehyde-3-phosphate dehydrogenase; metabolic enzyme involved in glycoloysis

2

Homolog of yeast RPL14/(RPL14e)

2

TWI1 (Tetrahymena piWI )

PAZ/Piwi Domain protein similar to Piwi/Argonaute; required for accumulation of
scnRNAs, elimination of IES and chromosome breakage during macronuclear
development; interacts with scnRNAs; involved in histone H3 lysine 9/27 methylations

2

Glutamine synthetase, catalytic domain containing protein

2

RPL25 (Ribosomal Protein of the
Large subunit #25)

Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23
containing protein

1

TTHERM_00494880‡

hypothetical protein

1

TTHERM_00051840

hypothetical protein

2

TTHERM_00849260‡

hypothetical protein

2

Homolog of yeast RPP0, human RPLP0, bacteria RPL10; Acidic ribosomal protein P0 of
the large subunit

2

TTHERM_00693060

enoyl-CoA hydratase/isomerase family protein

1

TTHERM_00497380†

oxidoreductase, zinc-binding dehydrogenase family protein

2

TTHERM_00434020

ribosomal protein S8.e containing protein

2

Alpha amylase, catalytic domain containing protein

2

TTHERM_00624780

metallopeptidase family M24 containing protein

1

TTHERM_00205180†‡

cyclic nucleotide-binding domain containing protein

2

TTHERM_00697490

TTHERM_01161040‡
TTHERM_01084100†‡
TTHERM_00134940

TTHERM_00636970†

TTHERM_01435670†

TTHERM_00497940†

RPP0 (Ribosomal Protein P0 of the
large subunit)

GLC3 (GLC3 Ortholog)

RRM34 (RNA recognition motifcontaining protein 34)

2

TTHERM_00402120†

Glutathione S-transferase, N-terminal domain containing protein

2

TTHERM_00537300†

ribose-phosphate pyrophosphokinase family protein

1

Profilin family protein; both inhibits and enhances actin polymerization; co-localizes
with actin in the division furrow

2

hypothetical protein

1

Lycopene biosynthesis-enhancing protein; similar to sigma cross-reacting protein 27A

1

TTHERM_00105430†

PRF1 (PRoFilin)

TTHERM_00128870
TTHERM_00600650

LBE1 (Lycopene BiosynthesisEnhancing )
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TTHERM_00348410‡

hypothetical protein

2

TTHERM_00498190‡

HHF1 (Histone H Four )

Histone H4; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein
core of the eukaryotic nucleosome; adjacent to HHT2; encoded protein identical to
Hhf2p; expressed during macronuclear S-phase

2

TTHERM_00484731

RRM28 (RNA recognition motifcontaining protein 28)

RNA recognition motif-containing protein

2

Homolog of Yeast RPL35, Bacterial RPL29

2

nucleosome assembly protein

2

Homolog of Yeast RPL31, Human RPL31

1

TTHERM_00773690†

adenylosuccinate synthetase family protein

2

TTHERM_01048110†

Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein

1

G-quartet DNA binding protein; shows preference for binding parallel G-DNAs; activity
localized predominantly in the nuclear fraction; knockout strain shows increased
occurrence of extra micronuclei; not essential for growth

2

TTHERM_00195860†

Thiolase, N-terminal domain containing protein

2

TTHERM_00657560†

hypothetical protein

2

TTHERM_00561680
TTHERM_00786930
TTHERM_00943010

TTHERM_00499420

RPL35 (Ribosomal Protein of the
Large subunit #35)
NAP1 (Nucleosome Assembly
Protein )
RPL31 (Ribosomal Protein of the
Large subunit #31)

TGP1 (Tetrahymena G-DNA
binding Protein )

TTHERM_00283180

HTB2 (Histone h Two B )

TTHERM_01207660

CDC2 (Cell Division Cycle )

Histone H2B; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein
core of the eukaryotic nucleosome; differs from Htb1p by three amino acids
Homolog of the catalytic subunit of the major cell cycle cyclin-dependent kinase (cdk);
studies suggest cdc2p phosphorylates HHO1; expression positively regulated by HHO1
phosphorylation during starvation, resulting in a positive feedback

1
1

TTHERM_00535740†

Mitochondrial carrier protein

1

TTHERM_00339700†

hypothetical protein

1

TTHERM_00499390†‡

Glycine cleavage system T protein. Sequence similarity to the HisK protein kinase
family

2

TTHERM_00052470†‡

AMP-binding enzyme family protein

1

TTHERM_00444470†

S-adenosylmethionine synthetase family protein

2

TTHERM_00196200†

isocitrate dehydrogenase, NADP-dependent family protein

1
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Glycolytic enzyme phosphoglucose isomerase, catalyzes the interconversion of glucose6-phosphate and fructose-6-phosphate.

2

TTHERM_00475310†

hypothetical protein

2

TTHERM_00530250

aldehyde dehydrogenase

1

pyruvate kinase; converts phosphoenolpyruvate to pyruvate during glycolysis

2

succinyl-CoA synthetase, beta subunit family protein

2

Homolog of yeast ASC1

2

TTHERM_00147510†

Coenzyme A transferase family protein

2

TTHERM_00194240

homeobox-containing protein-related

1

TTHERM_00448660†‡

hypothetical protein

1

TTHERM_00927250‡

oxidoreductase, short chain dehydrogenase/reductase family protein

1

TTHERM_00185350

ubiquitin-activating enzyme

1

TTHERM_01035530

thioesterase family protein

1

TTHERM_00243730†

Glucosamine-6-phosphate isomerase/6-phosphogluconolactonase family protein

2

TTHERM_00433610

PCI domain containing protein

1

tRNA methyltransferase

1

TTHERM_00241740

Thioredoxin family protein

1

TTHERM_00429910†

cytidyltransferase-related domain containing protein

1

Homolog of yeast RPS23, human RPS23 and bacterial RPS12; small (40S) ribosomal
subunit protein with sequence similarity to E.coli ribosomal protein S12

2

Peptidase M16 inactive domain containing protein

2

phenylalanyl-tRNA synthetase, alpha subunit family protein

1

TTHERM_00332160

hypothetical protein

1

TTHERM_00388400†

hypothetical protein

1

TTHERM_01108700

TTHERM_00118600†

PGI1 (PhosphoGlucoIsomerase)

PYK1 (PYruvate Kinase)

TTHERM_00437600
TTHERM_01113100

TTHERM_00621400

TTHERM_00434040

RACK1 (Receptor for Activated C
Kinase 1)

TRM8 (tRNA methyltransferase 8)

RPS12 (Ribosomal Protein of the
Small subunit )

TTHERM_00836690†
TTHERM_00133690†

FRS1 (phenylalanyl-tRNA
synthetase 1)
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TTHERM_00220990‡

Protein kinase domain containing protein. Sequence similarity to a protein kinase family
unique to Tetrahymena thermophila

1

TTHERM_00148900‡

hypothetical protein

1

P68-like protein, putative

1

AMP-binding enzyme family protein

2

TTHERM_00190830†‡

DRH1 (DExD/H box RNA helicase
1)

TTHERM_00382380†
TTHERM_00549610‡

RPB81 (RNA polymerase II
subunit 8A)

Subunit shared in RNA polymerases I, II & III

1

TTHERM_00149340†

CCT2 (CCT2 Ortholog)

TCP-1/cpn60 chaperonin family protein

1

TTHERM_00790590‡

Protein kinase domain containing protein. Sequence similarity to the ULK protein kinase
family

1

TTHERM_00343440†

conserved hypothetical protein

1

TTHERM_00614859†

conserved hypothetical protein

1

TTHERM_00383610

Citrate synthase family protein

1

TTHERM_00476640

Ribosomal protein L24e containing protein

1

TTHERM_00046920†

TATA box-binding protein

1

TTHERM_00464990

DNA topoisomerase family protein

1

TTHERM_00035180†

acetoacetate decarboxylase

1

glutaminyl-tRNA synthetase family protein

1

TTHERM_00056140†‡
TTHERM_00780960
TTHERM_00134940
TTHERM_00660180‡

ERS3 (glutaminyl-tRNA synthetase
3)
RPL27 (Ribosomal Protein of the
Large subunit #27)
RPL25 (Ribosomal Protein of the
Large subunit #25)
HMGB (High Mobility Group)

TTHERM_00408760†‡
TTHERM_00023980†‡
TTHERM_00353480†

RAN1 (RAN GTPase)

1
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23
containing protein
High-Mobility-Group (HMG) protein; induces negative supercoiling of DNA in vitro;
present in both macro- and micronuclei but with elevated expression during both
macronuclear S phase and endoreplication of developing new macronuclei

1
1

Ubiquitin carboxyl-terminal hydrolase family protein

1

Putative Ran GTPase; an evolutionarily conserved small GTPase with roles in nuclear
transport, mitotic spindle assembly and nuclear envelope assembly

1

HELP domain containing protein

1
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TTHERM_00812780

RPL38 (Ribosomal Protein of the
Large subunit #38)

Homolog of Yeast RPL38

1

TTHERM_00118610

ATP synthase F1, gamma subunit family protein

1

TTHERM_00655520‡

Copper/zinc superoxide dismutase family protein

1

† indicates proteins that appeared in Ubc9p native purification during vegetative growth
‡ indicates proteins that are up-regulated during conjugation
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Table 5: List of Ubc9p conjugation-specific interacting proteins in Tetrahymena.
Gene Name

Standard Name

TTHERM_01006550

Description
Thioredoxin family protein

Times
identified
1

Citrate synthase; bifunctional 14-nm filament-forming protein; structural protein involved in
oral morphogenesis and pronuclear behavior during conjugation; citrate synthase activity
decreased by polymerization and dephosphorylation

2

TTHERM_00622710

Pyridine nucleotide-disulphide oxidoreductase family protein

2

TTHERM_00655820

translation elongation factor EF-1, subunit alpha

2

TTHERM_00529790

CIT1 (CITrate synthase)

TTHERM_00191720

2

TTHERM_00777260

hypothetical protein

2

TTHERM_01084110

Glutamine synthetase

2

TTHERM_00487140

hypothetical protein

1

TTHERM_00160770

FTT49 (14-3-3 protein)

14-3-3 protein

1

TTHERM_00697490

RPL14 (Ribosomal protein of
the large subunit)

Homolog of yeast RPL14/(RPL14e)

2

TTHERM_01161040

TWI1 (Tetrahymena piWI )

TTHERM_00134940

RPL25 (Ribosomal Protein of
the Large subunit #25)

PAZ/Piwi Domain protein similar to Piwi/Argonaute; required for accumulation of
scnRNAs, elimination of IES and chromosome breakage during macronuclear development;
interacts with scnRNAs; involved in histone H3 lysine 9/27 methylations
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23
containing protein

2
1

TTHERM_00494880

hypothetical protein

1

TTHERM_00051840

hypothetical protein

2

TTHERM_00849260

hypothetical protein

2

TTHERM_00693060

enoyl-CoA hydratase/isomerase family protein

1

TTHERM_00434020

ribosomal protein S8.e containing protein

2

TTHERM_00624780

metallopeptidase family M24 containing protein

1
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TTHERM_00128870
TTHERM_00600650

LBE1 (Lycopene BiosynthesisEnhancing )

TTHERM_00348410
TTHERM_00498190
TTHERM_00484731
TTHERM_00561680
TTHERM_00786930
TTHERM_00943010

HHF1 (Histone H Four )
RRM28 (RNA recognition
motif-containing protein 28)
RPL35 (Ribosomal Protein of
the Large subunit #35)
NAP1 (Nucleosome Assembly
Protein )
RPL31 (Ribosomal Protein of
the Large subunit #31)

TTHERM_00499420

TGP1 (Tetrahymena G-DNA
binding Protein )

TTHERM_00283180

HTB2 (Histone h Two B )

TTHERM_01207660

CDC2 (Cell Division Cycle )

TTHERM_01108700

PGI1 (PhosphoGlucoIsomerase)

hypothetical protein

1

Lycopene biosynthesis-enhancing protein; similar to sigma cross-reacting protein 27A

1

hypothetical protein

2

Histone H4; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein core
of the eukaryotic nucleosome; adjacent to HHT2; encoded protein identical to Hhf2p;
expressed during macronuclear S-phase

2

RNA recognition motif-containing protein

2

Homolog of Yeast RPL35, Bacterial RPL29

2

nucleosome assembly protein

2

Homolog of Yeast RPL31, Human RPL31

1

G-quartet DNA binding protein; shows preference for binding parallel G-DNAs; activity
localized predominantly in the nuclear fraction; knockout strain shows increased occurrence
of extra micronuclei; not essential for growth
Histone H2B; one of the four histones (H2A, H2B, H3 and H4) that comprise the protein
core of the eukaryotic nucleosome; differs from Htb1p by three amino acids
Homolog of the catalytic subunit of the major cell cycle cyclin-dependent kinase (cdk);
studies suggest cdc2p phosphorylates HHO1; expression positively regulated by HHO1
phosphorylation during starvation, resulting in a positive feedback
Glycolytic enzyme phosphoglucose isomerase, catalyzes the interconversion of glucose-6phosphate and fructose-6-phosphate.

2
1
1
2

TTHERM_00530250

aldehyde dehydrogenase

1

TTHERM_00437600

succinyl-CoA synthetase, beta subunit family protein

2

Homolog of yeast ASC1

2

TTHERM_00194240

homeobox-containing protein-related

1

TTHERM_00927250

oxidoreductase, short chain dehydrogenase/reductase family protein

1

TTHERM_00185350

ubiquitin-activating enzyme

1

TTHERM_01035530

thioesterase family protein

1

TTHERM_00433610

PCI domain containing protein

1

TTHERM_01113100

RACK1 (Receptor for
Activated C Kinase 1)

65

TTHERM_00621400

TRM8 (tRNA
methyltransferase 8)

tRNA methyltransferase

1

Thioredoxin family protein

1

Homolog of yeast RPS23, human RPS23 and bacterial RPS12; small (40S) ribosomal
subunit protein with sequence similarity to E.coli ribosomal protein S12

2

TTHERM_00332160

hypothetical protein

1

TTHERM_00220990

Protein kinase domain containing protein. Sequence similarity to a protein kinase family
unique to Tetrahymena thermophila

1

TTHERM_00148900

hypothetical protein

1

Subunit shared in RNA polymerases I, II & III

1

TTHERM_00790590

Protein kinase domain containing protein. Sequence similarity to the ULK protein kinase
family

1

TTHERM_00383610

Citrate synthase family protein

1

TTHERM_00476640

Ribosomal protein L24e containing protein

1

TTHERM_00464990

DNA topoisomerase family protein

1

TTHERM_00241740
TTHERM_00434040

TTHERM_00549610

TTHERM_00780960
TTHERM_00134940

RPS12 (Ribosomal Protein of
the Small subunit )

RPB81 (RNA polymerase II
subunit 8A)

RPL27 (Ribosomal Protein of
the Large subunit #27)
RPL25 (Ribosomal Protein of
the Large subunit #25)

TTHERM_00660180

HMGB (High Mobility Group)

TTHERM_00812780

RPL38 (Ribosomal Protein of
the Large subunit #38)

1
Homolog of Yeast RPL25, Human RPL23A, Bacteria RPL23; Ribosomal protein L23
containing protein
High-Mobility-Group (HMG) protein; induces negative supercoiling of DNA in vitro;
present in both macro- and micronuclei but with elevated expression during both
macronuclear S phase and endoreplication of developing new macronuclei

1
1

Homolog of Yeast RPL38

1

TTHERM_00118610

ATP synthase F1, gamma subunit family protein

1

TTHERM_00655520

Copper/zinc superoxide dismutase family protein

1
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Table 6: Putative “junk” proteins that appeared in three unrelated Tetrahymena purifications.
Gene Name

Standard Name

Description

TTHERM_00194650

TRS1 (Threonyl-tRNA
synthetase 1)

threonyl-tRNA synthetase family protein

TTHERM_00794020

glycine dehydrogenase family protein

TTHERM_00105110

HSP70 (Heat Shock Protein )

Putative 70-kDa heat-shock protein (hsp70)

TTHERM_00171850

SSA6 (HSP70a paralog)

dnak protein BiP

TTHERM_00926980
TTHERM_00114360

acetyl-CoA acyltransferases family protein
SRS1 (seryl-tRNA synthetase
1)

seryl-tRNA synthetase family protein

HSP82 (Heat Shock Protein )

Hsp90 family member; 82 kDa heat shock-inducible protein

TTHERM_00353280
TTHERM_00158520

adenosylhomocysteinase family protein

TTHERM_00047080

succinate dehydrogenase, flavoprotein subunit containing protein

TTHERM_00794110

dehydrogenase, isocitrate/isopropylmalate family protein

TTHERM_00268070

2-oxoglutarate dehydrogenase, E1 component family protein

TTHERM_00190950

ACT1 (ACTin)

Actin; structural protein; monomeric subunits of the actin protein (G-actin) polymerize to form structural
filiaments (F-actin); localized to the cleavage forrow during cytokinesis

TTHERM_01049200

Glutamate/Leucine/Phenylalanine/Valine dehydrogenase family protein

TTHERM_00128330

Amylo-alpha-1,6-glucosidase family protein

TTHERM_01084370

TPA8 (Tetrahymena P-type
ATPase )

P-type ATPase; putative sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA); constitutively
expressed; starvation downregulates expression

TTHERM_00196370

HSP60 (Heat Shock Protein)

HSP60; TCP-1/cpn60 chaperonin family protein

TTHERM_01014750
TTHERM_00052310

AAC (ADP/ATP Carrier)

dnaK protein
Hydrogenosomal ADP/ATP carrier protein

TTHERM_00954380

2-oxoglutarate dehydrogenase, E1 component family protein

TTHERM_00241700

succinate dehydrogenase and fumarate reductase iron-sulfur protein

TTHERM_00725970

glycosyl transferase, group 1 family protein
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TTHERM_00043870

TGP2 (Tetrahymena G-DNA
binding Protein )

TTHERM_00151810
TTHERM_00059330
TTHERM_00616050

DRS1 (Aspartyl-tRNA
synthetase 1)

G-quartet DNA binding protein; has dihydrolipoamide dehydrogenase (DLDH) activity; preferentially
binds G4-DNA oligonucleotides with adjacent single-stranded domains
Elongation factor Tu, mitochondrial precursor, putative
hypothetical protein
aspartyl-tRNA synthetase family protein

TTHERM_00535260

succinyl-CoA synthetase, beta subunit family protein

TTHERM_00695650
TTHERM_00237560

AMP-binding enzyme family protein
AMP-binding enzyme family protein

TTHERM_00571650
TTHERM_00221140

hypothetical protein
ARS2 (alanyl-tRNA synthetase
2)

TTHERM_00899460
TTHERM_00487020
TTHERM_00938820

alanyl-tRNA synthetase family protein
acetyl-CoA acyltransferases family protein

PRS1 (Prolyl-tRNA synthetase
1)
EEF2 (Eukaryotic translation
Elongation Factor )

TTHERM_00864870

prolyl-tRNA synthetase family protein
Translation elongation factor 2; catalyzes ribosomal translocation during protein synthesis; mRNA is
expressed during vegetative growth; high amino acid identity with EF-2 in other eukaryotes
hypothetical protein

TTHERM_00486480

ENO1 (ENOlase)

Enolase; portions of this gene may have been laterally transferred

TTHERM_00122290

TCP1 (TCP1 Ortholog)

TCP-1/cpn60 chaperonin family protein

TTHERM_00529860
TTHERM_00193230
TTHERM_00691520
TTHERM_00339640
TTHERM_00691890

VMA2 (Vacuolar Membrane
Atpase)
PDA1 (Pyruvate
Dehydrogenase Alpha 1)

pyruvate dehydrogenase complex E1 component, catalyzes the direct oxidative decarboxylation of
pyruvate to acetyl-CoA

KRS1 (lysyl-tRNA synthetase)

lysyl-tRNA synthetase family protein

VMA1 (Vacuolar Membrane
Atpase)
NRS1 (asparaginyl-tRNA
synthetase 1)

V-type ATPase, B subunit family protein

V-type ATPase, A subunit family protein
asparaginyl-tRNA synthetase family protein

TTHERM_00037060

CCT8 (CCT8 Ortholog)

TCP-1/cpn60 chaperonin family protein

TTHERM_00469380

DRH14 (DExD/H box RNA
helicase 14)

DEAD/DEAH box helicase family protein

TTHERM_00429890

hypothetical protein

TTHERM_00471950

hypothetical protein
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TTHERM_00193640

2-oxoglutarate dehydrogenase, E1 component family protein

TTHERM_00068140

succinyl-CoA synthetase, alpha subunit family protein

TTHERM_00616340

HEAT repeat family protein

TTHERM_01394370

hypothetical protein

TTHERM_00239290

CCT3 (CCT3 Ortholog)

TCP-1/cpn60 chaperonin family protein

TTHERM_00859260

EF-1 guanine nucleotide exchange domain containing protein

TTHERM_00723390

dehydrogenase, isocitrate/isopropylmalate family protein

TTHERM_00013760

hypothetical protein

TTHERM_00365340

AAA family ATPase, CDC48 subfamily protein

TTHERM_00046920

TATA box-binding protein

TTHERM_00344030

dehydrogenase, isocitrate/isopropylmalate family protein

TTHERM_00037050

CCT4 (CCT4 Ortholog)

TTHERM_00979780
TTHERM_01197120

TCP-1/cpn60 chaperonin family protein
Transketolase, pyridine binding domain containing protein

DRH18 (DExD/H box RNA
helicase 18)

DEAD/DEAH box helicase family protein

TTHERM_00151670

oxidoreductase, zinc-binding dehydrogenase family protein

TTHERM_00802450

Mitochondrial carrier protein

TTHERM_00502240

Carbamoyl-phosphate synthase L chain, ATP binding domain containing protein

TTHERM_00285620

NAC domain containing protein

TTHERM_00474970

60s Acidic ribosomal protein

TTHERM_00549480

Thioredoxin family protein

TTHERM_00497960

CCT7 (Chaperonin Containing
TCP-1 )

CCT-eta chaperonin subunit; expressed during cilia biogenesis and conjugation

TTHERM_00338470

PFK3 (PhosphoFructoKinase)

Alpha subunit of heterooctameric phosphofructokinase

TTHERM_00446390

small GTP-binding protein domain containing protein

69

TTHERM_00363210
TTHERM_00670500

Mitochondrial carrier protein
CCT6 (CCT6 Ortholog)

TCP-1/cpn60 chaperonin family protein

TTHERM_00459390

CTP synthase family protein

TTHERM_00735240

small GTP-binding protein domain containing protein

TTHERM_00134970

CCT5 (CCT5 Ortholog)

TCP-1/cpn60 chaperonin family protein

TTHERM_00925340

hypothetical protein

TTHERM_00998940

hypothetical protein

TTHERM_00046480

ENO2 (ENOlase)

enolase family protein

TTHERM_00028740

RPL12 (Ribosomal Protein of
the Large subunit #12)

Homolog of Yeast RPL12, Human RPL12, Bacterial RPL11; Ribosomal protein L11; RNA binding
domain containing protein

TTHERM_00829380
TTHERM_00275740
TTHERM_00338460

RPL11 (Ribosomal protein of
the large subunit)
CHC1 (Clathrin Heavy Chainlike protein)
PFK2 (PhosphoFructoKinase)

Homolog of yeast RPL11(/RPL5)and E.coli RPL5
Region in Clathrin and VPS family protein
Beta subunit of heterooctameric Phosphofructokinase

TTHERM_00715730

Calpain family cysteine protease containing protein

TTHERM_00476820

TIP49 C-terminus family protein

TTHERM_00377330

hypothetical protein

TTHERM_00049030

Na,H/K antiporter P-type ATPase, alpha subunit family protein

TTHERM_00659010

hypothetical protein

TTHERM_00584700

Protein kinase domain. Sequence similarity to a protein kinase family unique to Tetrahymena thermophila

TTHERM_00725990
TTHERM_00657270

hypothetical protein
RRS1 (arginyl-tRNA
synthetase 1)

arginyl-tRNA synthetase family protein

TTHERM_00268030

Polyprenyl synthetase family protein

TTHERM_00527090

PBS lyase HEAT-like repeat family protein

TTHERM_00773720

hypothetical protein

TTHERM_00424720

hypothetical protein
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TTHERM_00047230

hypothetical protein

TTHERM_00161250

hypothetical protein

TTHERM_00865270

DnaJ domain containing protein

TTHERM_01513260
TTHERM_00929450
TTHERM_00114360

TTHERM_00317440

BBC49

hypothetical protein

PGK1 (PhosphoGlycerate
Kinase )
SRS1 (seryl-tRNA synthetase
1)
MFE1 (Fusion of peroxisomal
multifunctional oxydation
protein and 2-enoyl-CoA
hydratase)

Phosphoglycerate kinase; glycolytic enzyme that catalyzes the conversion of 3-phospho-D-glycerate to 3phospho-D-glyceroyl phosphate

TTHERM_00052400
TTHERM_00131110
TTHERM_00823670
TTHERM_00149300
TTHERM_00454080
TTHERM_01146030
TTHERM_00762890
TTHERM_00475140

Fusion of peroxisomal multifunctional oxydation protein and 2-enoyl-CoA hydratase
Cystathionine beta-lyase

RPS18 (Ribosomal Protein of
the Small subunit 18)
RPS19 (Ribosomal Protein of
the Small subunit 19)
RPS4 (Ribosomal Protein of
the Small subunit 4)
RPS22 (Ribosomal Protein of
the Small subunit 22)
CAT1 (CATalase )
RPS17 (Ribosomal Protein of
the Small subunit 17)
PDI1 (Protein DisulfideIsomerase)

TTHERM_00777250
TTHERM_00773340

seryl-tRNA synthetase family protein

Homolog of yeast RPS18, human RPS18, bacterial RPS13
Homolog of yeast RPS19, human RPS19;
Homolog of yeast RPS4, human RPS4;
Homolog of yeast RPS22, bacterial RPS8;
Catalase; peroxisomal enzyme involved in the metabolism of hydrogen peroxide; enzyme activity induced
by linolenic acid
Homolog of yeast RPS17, human RPS17
protein disulfide-isomerase domain containing protein
hypothetical protein

RPL8 (Ribosomal protein of
the large subunit)

Homolog of Yeast RPL8, Human RPL7A, Archaeal RPL7AE;
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CHAPTER 4 DISCUSSION AND FUTURE PERSPECTIVE

Since the discovery of SUMO in 1996, efforts have been focused on the identification of
its cellular targets in order to characterize the functional consequences of SUMOylation.
In this study, we combined phenotypic study as well as proteomic study to elucidate
cellular functions of SUMOylation in Tetrahymena thermophila during vegetative growth
and sexual reproduction. Our proteomic analyses and genetic analyses all support roles of
SUMOylation in regulating mitosis, metabolism, ribosome biogenesis, progression
through conjugation, heat shock response and MAC development.
Ubc9p regulates cell cycle progression and chromosomal segregation
One of the first roles discovered for SUMOylation was in regulation of the cell cycle
progression in numerous model systems [99,149,150]. We have demonstrated that there
is a requirement for SUMOylation in Tetrahymena mitosis. We found that complete
deletion of UBC9 was lethal, a result consistent with studies in other organisms
[13,38,48,136]. However, reduced expression of UBC9 resulted in distinct phenotypes in
MICs. The MICs were lost from UBC9-depleted cells during vegetative growth. Having a
separate mitotic nucleus that does not contribute to gene expression makes Tetrahymena
a unique system for this study as other organisms will die aneuploidy nuclei. Our model
is that there is little to no DNA that is distributed to the MIC during mitosis due to
chromosome mis-segregation events that occur as a result of UBC9 depletion. This is
supported by the observation of unequal signal in dividing nuclei in DAPI stained cells
during mitosis (Fig. 8C). The requirement for SUMOylation in chromosome segregation
is well established in other species [45,109,151,152]. In budding yeast, deficiency in
SUMOylation brought upon by deletion of UBC9 results in gross defects in chromosome
structure and integrity as well as aberrant segregation and polyploidy [39]. On the other
hand, we observe that Tetrahymena cells expressing catalytically inactive dominant
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negative Ubc9p have multiple MICs. This could be explained if dominant-negative Ubc9
expression prevents MAC division and/or cytokinesis but MIC division is unaffected. In
this case, the single MIC undergoes one or more divisions without cytokinesis occurring
which would indicate a requirement of SUMOylation in cytokinesis. A multi-nucleate
phenotype was observed by Hayashi et al in a large number of chicken cells expressing a
conditional UBC9 mutant [38]. Septins are proteins have that been identified as high
abundant substrates of SUMO in budding yeast during mitosis. Septins are SUMOmodified prior to anaphase and disappear abruptly at cytokinesis. Only SUMOylated
septins have been observed to accumulate at the bud neck in mother cells[153] in yeast.
These results all suggest that Ubc9p plays an indispensable role in Tetrahymena mitosis
either through regulating cytokinesis or controlling chromosome segregation.
In agreement with the diverse cell cycle defects in SUMO mutants in model systems, we
identified a Cell Division Cycle protein 2 (CDC2) as an Ubc9p interacting partner in our
proteomic screen. CDC2, also known as cyclin dependent kinase 1 (Cdk1), is a key
regulator in cell cycle regulation that functions as a serine/threonine kinase [154]. It is
possible that SUMOylation of Cdc2 is necessary for its role in regulating progression of
the cell cycle. Alternatively, Ubc9 in Tetrahymena may be a substrate of Cdc2
phosphorylation as it is in human [155]. Another Ubc9p interacting protein that we
identified is DNA topoisomerase I (TOPO I) which has been previously reported as
SUMO substrate, as well as a Ubc9 interacting protein [156]. TOPO I was SUMO
conjugated in a Ubc9p-dependent manner and its interaction with SUMO and Ubc9p was
required for TOPO I-mediated DNA damage repair.
This loss-of-MIC phenotype is particularly interesting to us, because it has not been
reported previously in other species. We have observed Tetrahymena cells devoid of
DAPI-detectable MICs are able to survive with a micronucleus that does not have DNA,
which makes it a unique organism that provides more opportunity to study genome
integrity. A similar mitotic phenotype has been described previously by Cui and
Gorovsky in Tetrahymena [157] where they identified a centromeric H3 protein, Cna1p,
which exhibits micronuclear DNA loss and unequal chromosome segregation during
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mitosis when CNA1 gene was partially knockdown in somatic macronucleus. CNA1 gene
encodes a centromere-specific histone H3 variants, termed CenH3s [158-160], that is
associated with centromeric DNA in place of the typical H3s associated with the rest of
the genome. CenH3s are functionally conserved [161] and are required for functional
centromeres and recruitment of other centromeric and spindle checkpoint proteins. CNA1
is essential for vegetative growth. Incomplete macronuclear knockout results in MICs
that are smaller than MICs in wild-type cells [157], rather than the loss-of-MIC
phenotype observed in our Ubc9p depletion cells. Small MICs do not seem to prevent
MIC mitosis, however, DNA is unequally distributed to daughter nuclei [157], which is
in line with our observation in cells with reduced expression of Ubc9p. There is evidence
that SUMOylation plays critical roles in centromere function. Saccharomyces cerevisiae
Slx5/8 complex is the founding member of a recently defined class of SUMO-targeted
ubiquitin ligases (STUbLs). Slx5 exhibits a unique centromeric location though genomewide biding analysis. Deletion of slx5 and slx 8 in yeast show severe mitotic defects that
include aneuploidy and spindle mispositioning. Yeast two-hybrid screening has identified
that Ubc9 interacts with three subunits of the S. cerevisiae centromere DNA-binding core
complex, CBF3 [122]. All of these point towards the role of SUMOylation in
centromere-specific functions during mitosis. It would be interesting to analyze whether
Cnap1 is a SUMOylation substrate.
Howard-Till et al have recently identified a protein that is part of the cohesion
components, termed Rec8 [162], which is shown to localize to mitotic and meiotic nuclei.
RNAi-induced depletion of Rec8 results in slow growth, as well as lagging chromosomes
in mitotic anaphase [162]. Immunoprecipitation of Rec8 followed by probing with antiSUMO antibody suggests that Rec8 is SUMOylated (R. Howard-Till personal
communication). This provides another model where SUMOylation regulates cohesion
which further controls chromosomal segregation.
SUMOylation in Tetrahymena conjugation
Tetrahymena thermophila increase transcript levels of SUMO pathway enzymes during
the sexual life cycle indicating that SUMOylation may be involved in the nuclear
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processes that occur during conjugation. Our studies demonstrate critical roles for Ubc9p
during the sexual life cycle of Tetrahymena. Crosses between cell lines that express the
dominant negative Ubc9 were delayed in meiosis and resulted in fewer true exconjugant
progeny than from wild-type controls (Shown in Table 2). In contrast, cell lines that were
depleted for Ubc9p did not form pairs and therefore could not complete any of the
subsequent stages of conjugation including meiosis and macronuclear development. This
non-pairing phenotype was unexpected yet there is precedent for a SUMOylation
requirement for mating in other species. In budding yeast, degradation of the yeast
mating type factor, α1 protein, requires SUMO Targeted Ubiquitin Ligases (STUbLs)
Slx5 and Slx8 [163]. The requirement for SUMOylation could result from direct
modification of protein in cell pairing, a signal transduction pathway or a transcriptional
pathway needed to produce mating proteins. Although future studies will be required to
evaluate these possibilities we can note one observation made from an abandoned project.
In an earlier study, we identified three SUMO E3 ligase candidates based on
domains/structures (Q. Yang and J. Forney unpublished data). Cell lines expressing GFPE3#3 (Candidate 3) were generated and we found that the fusion protein localized at the
junctions of conjugating cells. It is possible that candidate 3 is a SUMO E3 ligase that
transfers SUMO to targets that are required for cell pairing. At that time we were
expecting nuclear SUMO E3 ligases so we did not pursue studies of this protein but in
view of the non-pairing phenotype this could be significant. The non-pairing phenotype
and delay in meiosis prevented us from analyzing the role of SUMOylation during
macronuclear development. To overcome this problem, future efforts will be focused on
developing alternative approaches such as inducible RNAi knockdown of SUMO
pathway genes or examination of SUMO substrate proteins during conjugation.
Ultimately we anticipate that severe defects will be discovered upon depletion of SUMO
pathway proteins. Previous studies demonstrated that RNAi-based silencing of Uba2p
and SUMO in Paramecium tetraurelia prevented the excision of IES during formation of
the somatic macronucleus [126]. Several conjugation-specific Ubc9 interacting proteins
have been identified from our proteomics screening. One such example is Twi1, which is
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an argonaute protein that is required in RNAi-mediated DNA rearrangements in
Tetrahymena macronuclear development [120].
Many known SUMO substrates regulate nuclear activity, including roles in transcription,
chromatin remodeling, DNA/RNA modification and DNA repair [164]. Surprisingly,
only a small fraction of the Ubc9p interacting proteins were classified as nuclear proteins
(~7 from vegetative cells and ~12 from mated samples). The reasons for this are unclear
but future efforts to identify additional nuclear Ubc9p interacting proteins may require
the purification of nuclei followed by protein purification and protein mass spectrometry.
Identification of Ubc9 interacting proteins using proteomics-based approach
Prior to 2004, identification of Ubc9p interacting protein was on performed using mostly
yeast two-hybrid screens and limited numbers of proteins were identified. However, the
discovery of proteomics methods dramatically changed this. One challenge that we are
constantly facing is that SUMOylation is a dynamic process with conjugation and deconjugation taking place concurrently, which means that at a given time in the cell, the
form of a particular substrate attached to Ubc9p or SUMO is present in very low
quantities, making detection of such protein-protein interactions very difficult. In
addition, different proteins will be SUMOylated under different cellular conditions at
different times. All these factors make it impossible for any single study to be
comprehensive. We are focusing on identification of Ubc9p interacting proteins during
Tetrahymena vegetative growth vs sexual reproduction. Ubc9p was N-terminal tagged
with (His)6 followed by (FLAG)3 tag. Purification was performed under native conditions
to protect the integrity of the protein complexes, followed by LC-MS protein mass
spectrometry. We identified 242 proteins from vegetative cells and 213 proteins from
conjugating samples. To verify the authenticity of these proteins as true interactors is
another challenge. One source of background is from high abundant “sticky” proteins. In
order to identify these “sticky” proteins and increase our confidence, we compared
proteins that we identified against those from two other Tetrahymena purifications
performed by Gould et al. and Smith et al. Proteins that appear in all three purifications
are ones which we consider to be low-confidence substrates. Proteins that are unique to
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our Ubc9p proteomic screen (they are not present in the two studies) are high-confidence
proteins. We have identified 128 such high confidence proteins from vegetative samples
(Veg.) and 106 from conjugating Tetrahymena (Conj.) (Table 7). In addition to a large
number of novel Ubc9p interacting proteins identified, the list includes orthologs of
previously identified Ubc9p interacting proteins or SUMO conjugates in other organisms
(e.g. Cdc2, TopI, EEF2, DRH19, multiple aminoacyl-tRNA synthetases and ribosomal
proteins)
Table 7: Comparison between numbers of proteins identified from
vegetative vs conjugating Tetrahymena based on biological function.
Veg.
Conj.
Metabolism
36
31
PTM & degradation
13
11
Signal transduction
4
2
Ribosome biogenesis
2
12
RNA processing
8
5
Translation
4
1
Structure maintenance
2
2
Response to cellular environment
10
4
Unknown
39
24
Transcription
4
4
Cell division
1
2
Transport
5
4
Chromatin remodeling
2
0
Tetrahymena Conjugation
2
0
Total
106
128

As shown in table 6, no proteins that are involved in chromatin remodeling and
Tetrahymena conjugation were identified from vegetative samples, while 2 proteins in
chromatin remodeling and 2 proteins involved in Tetrahymena conjugation were
identified from conjugating samples. In addition, increased numbers of ribosomal
proteins were identified in conjugating samples compares to vegetative samples (12 vs 2).
In 2013, Dr. Brian Raught’s laboratory reported 97 high-confidence Ubc9p interacting
proteins in budding yeast using affinity purification-coupled mass spectrometry approach
[146]. Four of these proteins were previously reported to be Ubc9 interactors, and 37
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have previously been identified as SUMO conjugants. Table 8 categorizes proteins
identified in yeast (S.c.) and Tetrahymena (T.t) based on their biological functions.
Table 8: Numbers of Ubc9 interacting proteins identified from
Ubc9p proteomics screens between Tetrahymena and yeast
T.t
S.c
Metabolism
36
19
PTM & degradation
13
1
Signal transduction
4
0
Ribosome biogenesis
2
21
RNA processing
8
9
Translation
4
5
Structure maintenance
2
3
Response to cellular environment
10
1
Unknown
39
8
Transcription
4
9
Cell division
1
5
Transport
5
7
Bud site selection
0
2
chromatin remodeling
0
7
Total
128
97

Many known SUMO substrates regulate nuclear activity, including roles in transcription,
chromatin remodeling, DNA/RNA modification and DNA repair [164]. Surprisingly,
only a small fraction of the Ubc9 interacting proteins were classified as nuclear proteins
(~7 from vegetative cells and ~12 from mated samples). The reasons for this are unclear
but future efforts to identify additional nuclear Ubc9p interacting proteins may require
the purification of nuclei followed by protein purification and protein mass spectrometry.
There is increasing evidence, however, that suggests SUMOylation is a less-centralized
process than expected and regulates several processes outside the nucleus including
membrane transport, mitochondrial activity, ribosomal biogenesis and heat shock stress
[6-8,91,165]. Indeed we identified several proteins that are involved in these processes.
SUMOylation and metabolism
Almost half of the Ubc9p interacting proteins we identified are classified as proteins in
metabolism (27-29% in vegetative and conjugating samples). It is not surprising that
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SUMO is known to modify and affect the function or regulate specific metabolic
enzymes within pathways. There is increasing evidence that SUMO is a key factor in
facilitating energy and nucleotide metabolism in response to cellular and environmental
cues, one such example is hypoxia [166]. Under the condition of hypoxia, increased
protein SUMOylation is observed. In addition, under hibernation, torpor and focal
cerebral ischaemia conditions, increased protein SUMOylation is also observed
[167,168]. These studies demonstrated that global protein SUMOylation is increased in
response to metabolic stress despite the fact that specific targets under these conditions
were not identified. A proposed model is that the basis of hypoxia-dependent increase in
global SUMOylation appears to involve, at least in part, transcriptional upregulation of
SUMO mRNA [166,169]. Researchers have also identified Hypoxia-induced factor (HIF)
as a SUMO substrate [169]. HIF is a central transcriptional regulator of a cell’s adaptive
response to hypoxia [170]. The regulation of transcriptional activity by SUMOylation
during hypoxic stress is one of the first observations establishing the relationship between
SUMOylation and metabolic stress response.
A second way by which the SUMO pathway may have an impact on metabolic processes
is through the regulation of the balance between mitochondrial fission and fusion, which
is critical for a number of processes including the maintenance of numbers of neuronal
synapses [2,171]. Several mitochondria proteins have been identified from our
immunoaffinity purification. They are either located in the mitochondrion (e.g. citrate
synthase), or they are involved in mitochondrial-related process (e.g. Mitochondrial
carrier protein).
SUMOylation and ribosomal biogenesis
The control of ribosome biogenesis is a critical cellular nodal point, which ensures that
protein synthesis is coordinated with cell growth and proliferation. The process is
initiated in the nucleolus, where the precursor forms of the small 40S and larger 60S
subunits are generated. Following cleavage and processing, these subunits are exported to
the cytoplasm for assembly into ribosomes. In the yeast Saccharomyces cerevisiae,
genetic studies have led to the identification of many critical components of the ribosome
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biogenesis pathway. Other biochemical approaches have enabled the isolation of specific
ribosomal pre-40S and pre-60S sub-complexes, which seem to function as intermediates
in the export of ribosomal particles to the cytoplasm [172]. Genetic studies in yeast also
revealed a role of the ubiquitin-like SUMO system in the formation and nuclear export of
pre-ribosomal particles [91]. Crucial roles of SUMOylation in mammalian ribosome
biogenesis have also been described [93,173]. We identified numerous proteins of the
ribosome complex in our proteomic screen in both vegetative and mating cells.
Moreover, we identified more proteins in the mated sample corresponding to MAC
development which would indicate the increased requirement of SUMO in protein
expression. We cannot differentiate whether these proteins are modified by SUMO in the
nucleus or in the cytoplasm but analysis of substrates prepared from nuclear extracts may
aid in differentiating between these alternatives.
SUMOylation and heat shock stress
All organisms need to be able to sense and react to extreme environmental conditions.
Without appropriate response such stresses can lead to cell damage or death. The heat
shock response is one of the most conserved and well-studied defense mechanism.
SUMOylation has been shown to involve in heat shock response. The levels of SUMO1
and SUMO2 conjugates were increased substantially followed the induction of heat
shock in Arabidopsis [174]. Overexpression of SUMO2 enhanced steady state levels of
SUMO2 conjugates in heat shock-induced accumulation. This accumulation was reduced
in an Arabidopsis line modified for increased thermotolerence by overexpressing the
cytosolic isoform of the Heat shock protein 70 (HSP70) chaperonin [174]. Following the
heat stress, SUMO conjugates pool were drastically increased in plants [164]. RNAi
knockdown of SUMO2 and SUMO3 substantially reduced cell survival after heat shock
[165]. In 2009, the Hay group utilized a system-level proteomics approach to describe
quantitative changed in protein modification with the SUMO2 paralog in mammalian
cells during response to heat shock. A massive redistribution of SUMO2 conjugates was
observed that affected many biological pathways [165]. Several Heat Shock Proteins,
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such as Hsp70 and Hsp71, were identified as Ubc9 interacting proteins in Tetrahymena
which is consistent with the role of SUMOylation in heat shock response.
Identification of SUMO interacting protein under native condition.
As an alternative approach to identify SUMO substrates, affinity purification of SUMO
protein was carried out to identify SUMO interacting proteins. SUMO was tagged with
the same dual tag that we described above (Q. Yang and J. Forney unpublished data). 78
proteins were identified, which includes proteins from several cellular processes, such as
metabolism, ribosome biogenesis, transcription, and stress response (Fig. 21 and Table
9). We compared Ubc9p vegetative list and SUMO vegetative list and found large
amount of proteins (52) that are common to both data sets (Fig. 22). There are two ways
to interpret these overlapping proteins - some of these are potential SUMO substrates or
SUMO E3 ligases that are interacting with both Ubc9p and SUMO, or it is also plausible
that these proteins represent background proteins present in both proteomic screens.

Fig. 21: Graphical representation of biological processes of SUMO interacting
proteins in Tetrahymena. 78 high-confidence SUMO interacting proteins were reported.
These proteins are categorized into different subsets based on their major functions,
including transcription, response to cellular environment, structure maintenance,
metabolism, translation, transport, ribosome biogenesis, RNA processing, PTM &
degradation and unknown.
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Fig. 22: Overlap between Ubc9p native purification and SUMO native purification
during Tetrahymena vegetative growth. There are 52 proteins that appeared in both
Ubc9 and SUMO two-step purifications.

Table 9: Number of proteins categorized by biological functions from
Ubc9p and SUMO proteomics screens
Ubc9p
SUMO
Metabolism
36
20
PTM & degradation
13
7
Signal transduction
4
2
Ribosome biogenesis
2
1
RNA processing
8
5
Translation
4
2
Structure maintenance
2
2
Response to cellular environment
10
7
Unknown
39
27
Transcription
4
3
Cell division
1
0
Transport
5
2
Total
128
78
Future perspectives
Different phenotypes were observed from cell lines depleted with Ubc9p (loss of MIC
phenotype) and cell lines expressing catalytic inactive Ubc9p (multiple MICs phenotype).
Loss-of-MIC phenotype was possibly attributed to the role of Ubc9p in chromosome
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segregation, however, the cause of multiple micronuclei was unclear. One hypothesis is
that cells expressing catalytic inactive Ubc9p causes defects in cytokinesis. Monitoring
cell number at various time points will provide initial evidence whether cytokinesis is
affected or not. One of the most abundant SUMOylated protein in budding yeast is septin
[175]. SUMO conjugation of septins is required for bud-neck ring formation during
cytokinesis [176]. It would be interesting to investigate SUMOylation of septins in the
cells expressing catalytic inactive Ubc9p.
Validation and characteristic of Ubc9p interacting proteins
TWI1 and HMGB were identified as conjugation-specific Ubc9p interacting proteins.
TWI1 is required for IES elimination in Tetrahymena macronuclear development [119].
In HMGB depleted Tetrahymena cells, mating was delayed and mating efficiency was
decreased [148]. We anticipate Ubc9p is required during Tetrahymena conjugation. Two
additional methods will be employed to validate interaction between Ubc9p and TWI1 or
HMGB. The first approach will validate Ubc9p interaction with TWI1 or HMGB by coimmunoprecipitation. Specifically, samples either wild-type untagged strain, tandemaffinity purified Ubc9p preparation will be separated by SDS-PAGE. Following this,
western blot analyses will be performed for TWI1 and HMGB using antibodies if they
are readily available. If antibodies are not available, we can express HA- or GST- tagged
TWI1 or HMGB. Western blotting can then be performed with anti-HA or anti-GST
antibody. A band corresponding to Twi1 or HMGB is expected in the Ubc9p preparation
as opposed to the control preparation. If such bands are observed, it would suggest that
these proteins interact with Ubc9p. Reverse immunoprecipitation will be employed that
proteins will be purified from tagged and untagged TWI1 or HMBG followed by probing
with anti-UBC9 antibody. Bands corresponding to Ubc9p are expected.
In order to analyze whether TWI1 or HMGB are SUMO substrates, tagged TWI1 or
HMGB will be affinity purified in cell lines expressing or depleted with UBC9. Western
blots will be probed with anti-SUMO antibody. A slower migration is expected in cell
lines expressing Ubc9p.
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The second approach involves the use of in vitro SUMOylation assay. Bacterial strains
will be engineered to express components of the SUMO pathway – SUMO, E1
heterodimer of Aos1p/Uba2p and Ubc9p and ATP. The advantage of such an assay is that
it does not require E3 SUMO ligases. GST-tagged TWI1 or HMGB will be incubated in
the presence of complete SUMO assay components after which proteins will be resolved
by SDS-PAGE and then western blotting with anti-GST antibodies. Presence of the
SUMO-modified form of TWI1 or HMGB will suggest that these are bona fide substrates
of SUMOp where attachment of SUMOp requires the use of the E2 Ubc9p. We will also
utilize SUMOplot (http://www.abgent.com/tools/) to identify putative SUMOylation
sites. These putative sties can be confirmed as actual sites of SUMOp attachment by
generating Lys mutants that are not SUMO-modified using the SUMOylation assay.
Affinity purification of nuclear Ubc9p interacting proteins.
It has been established that SUMOylation regulates various nuclear activities.
Surprisingly, only a small fraction of the Ubc9p interacting proteins were classified as
nuclear proteins with possible reason being most nuclear proteins are not released from
the nucleus. Future effort should be focused on identify additional nuclear Ubc9p
interacting proteins through protein purification followed by protein mass spectrometry.
Two nuclei isolation and purification protocols are described previously by Sweet and
Allis [177,178].
Identification and characteristic of SUMO E3 ligases.
Unlike Ubiquitin E3 ligases, not much is known about SUMO E3 ligases. Identification
of SUMO E3 ligases will provide insights into the regulation of SUMOylation. We
initially identify three SUMO E3 ligases candidates (TTHERM_00348490,
TTHERM_00442270, TTHERM_00227730) based on bioinformatics approach.
Knockout cell strain and cells expressing GFP-tagged E3#3 were generated. E3#3
localized to conjugation junction in Tetrahymena, which is interesting now and possibly
in line with the role of UBC9 in Tetrahymena paring. In order to further characterize this
being SUMO E3 ligase, global SUMOylation will be analyzed with reduced expression
of E3 candidates.
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